EP4153770A2 - Enhancement of kinase target engagement - Google Patents
Enhancement of kinase target engagementInfo
- Publication number
- EP4153770A2 EP4153770A2 EP21742931.5A EP21742931A EP4153770A2 EP 4153770 A2 EP4153770 A2 EP 4153770A2 EP 21742931 A EP21742931 A EP 21742931A EP 4153770 A2 EP4153770 A2 EP 4153770A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- mouse
- human
- kinase
- variant
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091000080 Phosphotransferase Proteins 0.000 title claims abstract description 201
- 102000020233 phosphotransferase Human genes 0.000 title claims abstract description 201
- 238000000034 method Methods 0.000 claims abstract description 95
- 239000011230 binding agent Substances 0.000 claims abstract description 77
- 239000000523 sample Substances 0.000 claims description 52
- 239000007787 solid Substances 0.000 claims description 32
- -1 tissue Substances 0.000 claims description 32
- 210000004027 cell Anatomy 0.000 claims description 29
- 238000006467 substitution reaction Methods 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 27
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical group C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 claims description 26
- 230000004927 fusion Effects 0.000 claims description 15
- 108060001084 Luciferase Proteins 0.000 claims description 14
- 239000005089 Luciferase Substances 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 14
- 239000013592 cell lysate Substances 0.000 claims description 11
- 239000002872 contrast media Substances 0.000 claims description 8
- 239000012472 biological sample Substances 0.000 claims description 7
- 238000000295 emission spectrum Methods 0.000 claims description 7
- 230000007613 environmental effect Effects 0.000 claims description 7
- 238000000695 excitation spectrum Methods 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 7
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 7
- 238000004949 mass spectrometry Methods 0.000 claims description 7
- HTBLMRUZSCCOLL-UHFFFAOYSA-N 8-benzyl-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-ol Chemical compound OC1=C(CC2=CC=CO2)N=C2N1C=C(N=C2CC1=CC=CC=C1)C1=CC=CC=C1 HTBLMRUZSCCOLL-UHFFFAOYSA-N 0.000 claims description 6
- 239000002616 MRI contrast agent Substances 0.000 claims description 6
- 239000006249 magnetic particle Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000013545 self-assembled monolayer Substances 0.000 claims description 6
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 6
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 5
- 239000010839 body fluid Substances 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 5
- 238000012634 optical imaging Methods 0.000 claims description 5
- 239000002094 self assembled monolayer Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 210000004671 cell-free system Anatomy 0.000 claims description 3
- 108060006633 protein kinase Proteins 0.000 abstract description 13
- 102000001253 Protein Kinase Human genes 0.000 abstract description 12
- 230000004186 co-expression Effects 0.000 abstract description 9
- 102100030708 GTPase KRas Human genes 0.000 description 41
- 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 41
- 108090000623 proteins and genes Proteins 0.000 description 39
- 235000018102 proteins Nutrition 0.000 description 38
- 102000004169 proteins and genes Human genes 0.000 description 38
- 125000005647 linker group Chemical group 0.000 description 34
- 239000002773 nucleotide Substances 0.000 description 32
- 125000003729 nucleotide group Chemical group 0.000 description 32
- 108090000765 processed proteins & peptides Proteins 0.000 description 31
- 150000001413 amino acids Chemical class 0.000 description 24
- 102000004196 processed proteins & peptides Human genes 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 108700043045 nanoluc Proteins 0.000 description 12
- 239000000975 dye Substances 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 238000000225 bioluminescence resonance energy transfer Methods 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 239000000700 radioactive tracer Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 230000037361 pathway Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000001708 Protein Isoforms Human genes 0.000 description 6
- 108010029485 Protein Isoforms Proteins 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 150000001350 alkyl halides Chemical class 0.000 description 6
- 229940043355 kinase inhibitor Drugs 0.000 description 6
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 6
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 102100037263 3-phosphoinositide-dependent protein kinase 1 Human genes 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 4
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 4
- 101001052490 Homo sapiens Mitogen-activated protein kinase 3 Proteins 0.000 description 4
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 4
- 101000628647 Homo sapiens Serine/threonine-protein kinase 24 Proteins 0.000 description 4
- 101000588553 Homo sapiens Serine/threonine-protein kinase Nek9 Proteins 0.000 description 4
- 101000983111 Homo sapiens Serine/threonine-protein kinase PAK 6 Proteins 0.000 description 4
- 101000864831 Homo sapiens Serine/threonine-protein kinase Sgk3 Proteins 0.000 description 4
- 108010047357 Luminescent Proteins Proteins 0.000 description 4
- 102000006830 Luminescent Proteins Human genes 0.000 description 4
- 102000043136 MAP kinase family Human genes 0.000 description 4
- 108091054455 MAP kinase family Proteins 0.000 description 4
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 4
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 description 4
- 102000008300 Mutant Proteins Human genes 0.000 description 4
- 108010021466 Mutant Proteins Proteins 0.000 description 4
- 102100026764 Serine/threonine-protein kinase 24 Human genes 0.000 description 4
- 102100031206 Serine/threonine-protein kinase N1 Human genes 0.000 description 4
- 102100031398 Serine/threonine-protein kinase Nek9 Human genes 0.000 description 4
- 102100026840 Serine/threonine-protein kinase PAK 6 Human genes 0.000 description 4
- 102100030071 Serine/threonine-protein kinase Sgk3 Human genes 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical class [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 102100033806 Alpha-protein kinase 3 Human genes 0.000 description 3
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 3
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 3
- 102100040862 Dual specificity protein kinase CLK1 Human genes 0.000 description 3
- 238000004435 EPR spectroscopy Methods 0.000 description 3
- 101000779572 Homo sapiens Alpha-protein kinase 3 Proteins 0.000 description 3
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 3
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 3
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 3
- 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 3
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 3
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical group C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 230000033077 cellular process Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 150000004775 coumarins Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 150000003732 xanthenes Chemical class 0.000 description 3
- SLLFVLKNXABYGI-UHFFFAOYSA-N 1,2,3-benzoxadiazole Chemical compound C1=CC=C2ON=NC2=C1 SLLFVLKNXABYGI-UHFFFAOYSA-N 0.000 description 2
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 2
- BNBQQYFXBLBYJK-UHFFFAOYSA-N 2-pyridin-2-yl-1,3-oxazole Chemical compound C1=COC(C=2N=CC=CC=2)=N1 BNBQQYFXBLBYJK-UHFFFAOYSA-N 0.000 description 2
- UWAUSMGZOHPBJJ-UHFFFAOYSA-N 4-nitro-1,2,3-benzoxadiazole Chemical compound [O-][N+](=O)C1=CC=CC2=C1N=NO2 UWAUSMGZOHPBJJ-UHFFFAOYSA-N 0.000 description 2
- 102100038079 AP2-associated protein kinase 1 Human genes 0.000 description 2
- 102100025995 AarF domain-containing protein kinase 1 Human genes 0.000 description 2
- 102100036409 Activated CDC42 kinase 1 Human genes 0.000 description 2
- 102100034111 Activin receptor type-1 Human genes 0.000 description 2
- 239000012099 Alexa Fluor family Substances 0.000 description 2
- 102100033805 Alpha-protein kinase 1 Human genes 0.000 description 2
- 102100033804 Alpha-protein kinase 2 Human genes 0.000 description 2
- 102100022014 Angiopoietin-1 receptor Human genes 0.000 description 2
- 102100039182 Ankyrin repeat and protein kinase domain-containing protein 1 Human genes 0.000 description 2
- 102100025511 Anti-Muellerian hormone type-2 receptor Human genes 0.000 description 2
- 102100035958 Atypical kinase COQ8A, mitochondrial Human genes 0.000 description 2
- 102100035952 Atypical kinase COQ8B, mitochondrial Human genes 0.000 description 2
- 102000004000 Aurora Kinase A Human genes 0.000 description 2
- 108090000461 Aurora Kinase A Proteins 0.000 description 2
- 102100032306 Aurora kinase B Human genes 0.000 description 2
- 102100026630 Aurora kinase C Human genes 0.000 description 2
- 108010014380 Autophagy-Related Protein-1 Homolog Proteins 0.000 description 2
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 description 2
- 102100024507 BMP-2-inducible protein kinase Human genes 0.000 description 2
- 102100025422 Bone morphogenetic protein receptor type-2 Human genes 0.000 description 2
- 102100025589 CaM kinase-like vesicle-associated protein Human genes 0.000 description 2
- 102100025227 Calcium/calmodulin-dependent protein kinase type II subunit gamma Human genes 0.000 description 2
- 102100040753 Casein kinase II subunit alpha' Human genes 0.000 description 2
- 102100034744 Cell division cycle 7-related protein kinase Human genes 0.000 description 2
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
- 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 2
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 2
- 102100023263 Cyclin-dependent kinase 10 Human genes 0.000 description 2
- 102100038111 Cyclin-dependent kinase 12 Human genes 0.000 description 2
- 102100038114 Cyclin-dependent kinase 13 Human genes 0.000 description 2
- 102100038113 Cyclin-dependent kinase 14 Human genes 0.000 description 2
- 102100033250 Cyclin-dependent kinase 15 Human genes 0.000 description 2
- 102100033245 Cyclin-dependent kinase 16 Human genes 0.000 description 2
- 102100033234 Cyclin-dependent kinase 17 Human genes 0.000 description 2
- 102100033144 Cyclin-dependent kinase 18 Human genes 0.000 description 2
- 102100033145 Cyclin-dependent kinase 19 Human genes 0.000 description 2
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
- 102100034741 Cyclin-dependent kinase 20 Human genes 0.000 description 2
- 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 2
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 2
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 2
- 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 2
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 2
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 2
- 102100031679 Cyclin-dependent kinase-like 1 Human genes 0.000 description 2
- 102100031685 Cyclin-dependent kinase-like 2 Human genes 0.000 description 2
- 102100031684 Cyclin-dependent kinase-like 3 Human genes 0.000 description 2
- 102100031683 Cyclin-dependent kinase-like 4 Human genes 0.000 description 2
- 102100034746 Cyclin-dependent kinase-like 5 Human genes 0.000 description 2
- 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 2
- 102100022204 DNA-dependent protein kinase catalytic subunit Human genes 0.000 description 2
- 108010031042 Death-Associated Protein Kinases Proteins 0.000 description 2
- 102100038587 Death-associated protein kinase 1 Human genes 0.000 description 2
- 102100038605 Death-associated protein kinase 2 Human genes 0.000 description 2
- 102100038606 Death-associated protein kinase 3 Human genes 0.000 description 2
- 102100040844 Dual specificity protein kinase CLK2 Human genes 0.000 description 2
- 102100040856 Dual specificity protein kinase CLK3 Human genes 0.000 description 2
- 102100040858 Dual specificity protein kinase CLK4 Human genes 0.000 description 2
- 102100036492 Dual specificity testis-specific protein kinase 1 Human genes 0.000 description 2
- 102100036498 Dual specificity testis-specific protein kinase 2 Human genes 0.000 description 2
- 102100023115 Dual specificity tyrosine-phosphorylation-regulated kinase 2 Human genes 0.000 description 2
- 102100023114 Dual specificity tyrosine-phosphorylation-regulated kinase 3 Human genes 0.000 description 2
- 102100023112 Dual specificity tyrosine-phosphorylation-regulated kinase 4 Human genes 0.000 description 2
- 102100029493 EKC/KEOPS complex subunit TP53RK Human genes 0.000 description 2
- 101150076616 EPHA2 gene Proteins 0.000 description 2
- 101150016325 EPHA3 gene Proteins 0.000 description 2
- 101150097734 EPHB2 gene Proteins 0.000 description 2
- 102100030011 Endoribonuclease Human genes 0.000 description 2
- 102100030013 Endoribonuclease Human genes 0.000 description 2
- 108010055211 EphA1 Receptor Proteins 0.000 description 2
- 108010055323 EphB4 Receptor Proteins 0.000 description 2
- 101150078651 Epha4 gene Proteins 0.000 description 2
- 101150025643 Epha5 gene Proteins 0.000 description 2
- 102100030322 Ephrin type-A receptor 1 Human genes 0.000 description 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 2
- 102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 2
- 102100021616 Ephrin type-A receptor 4 Human genes 0.000 description 2
- 102100021605 Ephrin type-A receptor 5 Human genes 0.000 description 2
- 102100021604 Ephrin type-A receptor 6 Human genes 0.000 description 2
- 102100021606 Ephrin type-A receptor 7 Human genes 0.000 description 2
- 102100021601 Ephrin type-A receptor 8 Human genes 0.000 description 2
- 102100030779 Ephrin type-B receptor 1 Human genes 0.000 description 2
- 102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 2
- 102100031982 Ephrin type-B receptor 3 Human genes 0.000 description 2
- 102100031983 Ephrin type-B receptor 4 Human genes 0.000 description 2
- 102100031984 Ephrin type-B receptor 6 Human genes 0.000 description 2
- 102100036725 Epithelial discoidin domain-containing receptor 1 Human genes 0.000 description 2
- 101710131668 Epithelial discoidin domain-containing receptor 1 Proteins 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- 102100026130 Extracellular tyrosine-protein kinase PKDCC Human genes 0.000 description 2
- 102100029531 Fas-activated serine/threonine kinase Human genes 0.000 description 2
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 2
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 2
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 2
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 2
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 2
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 2
- 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 2
- 102100037813 Focal adhesion kinase 1 Human genes 0.000 description 2
- 102100023734 G protein-coupled receptor kinase 4 Human genes 0.000 description 2
- 102100023685 G protein-coupled receptor kinase 5 Human genes 0.000 description 2
- 102100023686 G protein-coupled receptor kinase 6 Human genes 0.000 description 2
- 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 2
- 102100022975 Glycogen synthase kinase-3 alpha Human genes 0.000 description 2
- 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 description 2
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 2
- 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 description 2
- 102100032827 Homeodomain-interacting protein kinase 2 Human genes 0.000 description 2
- 102100032826 Homeodomain-interacting protein kinase 3 Human genes 0.000 description 2
- 102100022603 Homeodomain-interacting protein kinase 4 Human genes 0.000 description 2
- 101000742699 Homo sapiens AP2-associated protein kinase 1 Proteins 0.000 description 2
- 101000720055 Homo sapiens AarF domain-containing protein kinase 1 Proteins 0.000 description 2
- 101000928956 Homo sapiens Activated CDC42 kinase 1 Proteins 0.000 description 2
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 2
- 101000779568 Homo sapiens Alpha-protein kinase 1 Proteins 0.000 description 2
- 101000779565 Homo sapiens Alpha-protein kinase 2 Proteins 0.000 description 2
- 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 description 2
- 101000889403 Homo sapiens Ankyrin repeat and protein kinase domain-containing protein 1 Proteins 0.000 description 2
- 101000693801 Homo sapiens Anti-Muellerian hormone type-2 receptor Proteins 0.000 description 2
- 101000875771 Homo sapiens Atypical kinase COQ8A, mitochondrial Proteins 0.000 description 2
- 101000875775 Homo sapiens Atypical kinase COQ8B, mitochondrial Proteins 0.000 description 2
- 101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 2
- 101000765862 Homo sapiens Aurora kinase C Proteins 0.000 description 2
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 description 2
- 101000762370 Homo sapiens BMP-2-inducible protein kinase Proteins 0.000 description 2
- 101000934635 Homo sapiens Bone morphogenetic protein receptor type-2 Proteins 0.000 description 2
- 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 2
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 2
- 101000990005 Homo sapiens CLIP-associating protein 1 Proteins 0.000 description 2
- 101000932896 Homo sapiens CaM kinase-like vesicle-associated protein Proteins 0.000 description 2
- 101000892015 Homo sapiens Casein kinase II subunit alpha' Proteins 0.000 description 2
- 101000945740 Homo sapiens Cell division cycle 7-related protein kinase Proteins 0.000 description 2
- 101000749824 Homo sapiens Connector enhancer of kinase suppressor of ras 2 Proteins 0.000 description 2
- 101000908138 Homo sapiens Cyclin-dependent kinase 10 Proteins 0.000 description 2
- 101000884345 Homo sapiens Cyclin-dependent kinase 12 Proteins 0.000 description 2
- 101000884348 Homo sapiens Cyclin-dependent kinase 13 Proteins 0.000 description 2
- 101000884374 Homo sapiens Cyclin-dependent kinase 14 Proteins 0.000 description 2
- 101000944355 Homo sapiens Cyclin-dependent kinase 15 Proteins 0.000 description 2
- 101000944357 Homo sapiens Cyclin-dependent kinase 16 Proteins 0.000 description 2
- 101000944358 Homo sapiens Cyclin-dependent kinase 17 Proteins 0.000 description 2
- 101000944345 Homo sapiens Cyclin-dependent kinase 19 Proteins 0.000 description 2
- 101000945708 Homo sapiens Cyclin-dependent kinase 20 Proteins 0.000 description 2
- 101000715946 Homo sapiens Cyclin-dependent kinase 3 Proteins 0.000 description 2
- 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 2
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 2
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 2
- 101000777728 Homo sapiens Cyclin-dependent kinase-like 1 Proteins 0.000 description 2
- 101000777764 Homo sapiens Cyclin-dependent kinase-like 2 Proteins 0.000 description 2
- 101000777768 Homo sapiens Cyclin-dependent kinase-like 3 Proteins 0.000 description 2
- 101000777775 Homo sapiens Cyclin-dependent kinase-like 4 Proteins 0.000 description 2
- 101000945692 Homo sapiens Cyclin-dependent kinase-like 5 Proteins 0.000 description 2
- 101000619536 Homo sapiens DNA-dependent protein kinase catalytic subunit Proteins 0.000 description 2
- 101000956145 Homo sapiens Death-associated protein kinase 1 Proteins 0.000 description 2
- 101000956149 Homo sapiens Death-associated protein kinase 3 Proteins 0.000 description 2
- 101000749294 Homo sapiens Dual specificity protein kinase CLK1 Proteins 0.000 description 2
- 101000749291 Homo sapiens Dual specificity protein kinase CLK2 Proteins 0.000 description 2
- 101000749304 Homo sapiens Dual specificity protein kinase CLK3 Proteins 0.000 description 2
- 101000749298 Homo sapiens Dual specificity protein kinase CLK4 Proteins 0.000 description 2
- 101000714159 Homo sapiens Dual specificity testis-specific protein kinase 1 Proteins 0.000 description 2
- 101000714156 Homo sapiens Dual specificity testis-specific protein kinase 2 Proteins 0.000 description 2
- 101001049990 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 2 Proteins 0.000 description 2
- 101001049991 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 3 Proteins 0.000 description 2
- 101001049983 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 4 Proteins 0.000 description 2
- 101001010787 Homo sapiens Endoribonuclease Proteins 0.000 description 2
- 101000898696 Homo sapiens Ephrin type-A receptor 6 Proteins 0.000 description 2
- 101000898708 Homo sapiens Ephrin type-A receptor 7 Proteins 0.000 description 2
- 101000898676 Homo sapiens Ephrin type-A receptor 8 Proteins 0.000 description 2
- 101001064150 Homo sapiens Ephrin type-B receptor 1 Proteins 0.000 description 2
- 101001064458 Homo sapiens Ephrin type-B receptor 3 Proteins 0.000 description 2
- 101001064451 Homo sapiens Ephrin type-B receptor 6 Proteins 0.000 description 2
- 101000691796 Homo sapiens Extracellular tyrosine-protein kinase PKDCC Proteins 0.000 description 2
- 101000917570 Homo sapiens Fas-activated serine/threonine kinase Proteins 0.000 description 2
- 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 2
- 101000878536 Homo sapiens Focal adhesion kinase 1 Proteins 0.000 description 2
- 101000829481 Homo sapiens G protein-coupled receptor kinase 4 Proteins 0.000 description 2
- 101000829476 Homo sapiens G protein-coupled receptor kinase 5 Proteins 0.000 description 2
- 101000829473 Homo sapiens G protein-coupled receptor kinase 6 Proteins 0.000 description 2
- 101000903717 Homo sapiens Glycogen synthase kinase-3 alpha Proteins 0.000 description 2
- 101001066404 Homo sapiens Homeodomain-interacting protein kinase 1 Proteins 0.000 description 2
- 101001066401 Homo sapiens Homeodomain-interacting protein kinase 2 Proteins 0.000 description 2
- 101001066389 Homo sapiens Homeodomain-interacting protein kinase 3 Proteins 0.000 description 2
- 101001045363 Homo sapiens Homeodomain-interacting protein kinase 4 Proteins 0.000 description 2
- 101000582922 Homo sapiens Inactive serine/threonine-protein kinase PLK5 Proteins 0.000 description 2
- 101000649963 Homo sapiens Inactive serine/threonine-protein kinase VRK3 Proteins 0.000 description 2
- 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 2
- 101000734676 Homo sapiens Inactive tyrosine-protein kinase PEAK1 Proteins 0.000 description 2
- 101000741965 Homo sapiens Inactive tyrosine-protein kinase PRAG1 Proteins 0.000 description 2
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 2
- 101001043754 Homo sapiens Inhibitor of nuclear factor kappa-B kinase subunit beta Proteins 0.000 description 2
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 2
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
- 101000926535 Homo sapiens Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 2
- 101000977768 Homo sapiens Interleukin-1 receptor-associated kinase 3 Proteins 0.000 description 2
- 101000977771 Homo sapiens Interleukin-1 receptor-associated kinase 4 Proteins 0.000 description 2
- 101000852255 Homo sapiens Interleukin-1 receptor-associated kinase-like 2 Proteins 0.000 description 2
- 101001050038 Homo sapiens Kalirin Proteins 0.000 description 2
- 101001137642 Homo sapiens Kinase suppressor of Ras 1 Proteins 0.000 description 2
- 101001137640 Homo sapiens Kinase suppressor of Ras 2 Proteins 0.000 description 2
- 101001005128 Homo sapiens LIM domain kinase 1 Proteins 0.000 description 2
- 101001042360 Homo sapiens LIM domain kinase 2 Proteins 0.000 description 2
- 101001064870 Homo sapiens Lon protease homolog, mitochondrial Proteins 0.000 description 2
- 101000573522 Homo sapiens MAP kinase-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 2
- 101001018978 Homo sapiens MAP kinase-interacting serine/threonine-protein kinase 2 Proteins 0.000 description 2
- 101001059429 Homo sapiens MAP/microtubule affinity-regulating kinase 3 Proteins 0.000 description 2
- 101001059427 Homo sapiens MAP/microtubule affinity-regulating kinase 4 Proteins 0.000 description 2
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 2
- 101001106413 Homo sapiens Macrophage-stimulating protein receptor Proteins 0.000 description 2
- 101001059535 Homo sapiens Megakaryocyte-associated tyrosine-protein kinase Proteins 0.000 description 2
- 101001018259 Homo sapiens Microtubule-associated serine/threonine-protein kinase 1 Proteins 0.000 description 2
- 101001018300 Homo sapiens Microtubule-associated serine/threonine-protein kinase 2 Proteins 0.000 description 2
- 101001018294 Homo sapiens Microtubule-associated serine/threonine-protein kinase 3 Proteins 0.000 description 2
- 101001018298 Homo sapiens Microtubule-associated serine/threonine-protein kinase 4 Proteins 0.000 description 2
- 101000573441 Homo sapiens Misshapen-like kinase 1 Proteins 0.000 description 2
- 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 2
- 101001011663 Homo sapiens Mixed lineage kinase domain-like protein Proteins 0.000 description 2
- 101000584208 Homo sapiens Myosin light chain kinase 2, skeletal/cardiac muscle Proteins 0.000 description 2
- 101000584177 Homo sapiens Myosin light chain kinase 3 Proteins 0.000 description 2
- 101000584181 Homo sapiens Myosin light chain kinase family member 4 Proteins 0.000 description 2
- 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 description 2
- 101000654298 Homo sapiens N-terminal kinase-like protein Proteins 0.000 description 2
- 101001109455 Homo sapiens NACHT, LRR and PYD domains-containing protein 6 Proteins 0.000 description 2
- 101000970023 Homo sapiens NUAK family SNF1-like kinase 1 Proteins 0.000 description 2
- 101000970025 Homo sapiens NUAK family SNF1-like kinase 2 Proteins 0.000 description 2
- 101000663003 Homo sapiens Non-receptor tyrosine-protein kinase TNK1 Proteins 0.000 description 2
- 101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 description 2
- 101001108314 Homo sapiens Nuclear receptor-binding protein Proteins 0.000 description 2
- 101000577339 Homo sapiens Nuclear receptor-binding protein 2 Proteins 0.000 description 2
- 101000585675 Homo sapiens Obscurin Proteins 0.000 description 2
- 101001113056 Homo sapiens PAN2-PAN3 deadenylation complex subunit PAN3 Proteins 0.000 description 2
- 101100244966 Homo sapiens PRKX gene Proteins 0.000 description 2
- 101000731078 Homo sapiens Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Proteins 0.000 description 2
- 101001126783 Homo sapiens Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform Proteins 0.000 description 2
- 101000983155 Homo sapiens Protein-associating with the carboxyl-terminal domain of ezrin Proteins 0.000 description 2
- 101000878540 Homo sapiens Protein-tyrosine kinase 2-beta Proteins 0.000 description 2
- 101000606502 Homo sapiens Protein-tyrosine kinase 6 Proteins 0.000 description 2
- 101000686031 Homo sapiens Proto-oncogene tyrosine-protein kinase ROS Proteins 0.000 description 2
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 2
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 2
- 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 101001109145 Homo sapiens Receptor-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 2
- 101001089266 Homo sapiens Receptor-interacting serine/threonine-protein kinase 3 Proteins 0.000 description 2
- 101001089248 Homo sapiens Receptor-interacting serine/threonine-protein kinase 4 Proteins 0.000 description 2
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 2
- 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 2
- 101000669917 Homo sapiens Rho-associated protein kinase 1 Proteins 0.000 description 2
- 101000669921 Homo sapiens Rho-associated protein kinase 2 Proteins 0.000 description 2
- 101000654257 Homo sapiens SCY1-like protein 2 Proteins 0.000 description 2
- 101000617778 Homo sapiens SNF-related serine/threonine-protein kinase Proteins 0.000 description 2
- 101000826081 Homo sapiens SRSF protein kinase 1 Proteins 0.000 description 2
- 101000826077 Homo sapiens SRSF protein kinase 2 Proteins 0.000 description 2
- 101000826079 Homo sapiens SRSF protein kinase 3 Proteins 0.000 description 2
- 101000701497 Homo sapiens STE20/SPS1-related proline-alanine-rich protein kinase Proteins 0.000 description 2
- 101000628578 Homo sapiens Serine/threonine-protein kinase 16 Proteins 0.000 description 2
- 101000628693 Homo sapiens Serine/threonine-protein kinase 25 Proteins 0.000 description 2
- 101000701393 Homo sapiens Serine/threonine-protein kinase 26 Proteins 0.000 description 2
- 101000880439 Homo sapiens Serine/threonine-protein kinase 3 Proteins 0.000 description 2
- 101000701391 Homo sapiens Serine/threonine-protein kinase 31 Proteins 0.000 description 2
- 101000701396 Homo sapiens Serine/threonine-protein kinase 33 Proteins 0.000 description 2
- 101000701395 Homo sapiens Serine/threonine-protein kinase 35 Proteins 0.000 description 2
- 101000701405 Homo sapiens Serine/threonine-protein kinase 36 Proteins 0.000 description 2
- 101000701401 Homo sapiens Serine/threonine-protein kinase 38 Proteins 0.000 description 2
- 101000880431 Homo sapiens Serine/threonine-protein kinase 4 Proteins 0.000 description 2
- 101000880461 Homo sapiens Serine/threonine-protein kinase 40 Proteins 0.000 description 2
- 101000771237 Homo sapiens Serine/threonine-protein kinase A-Raf Proteins 0.000 description 2
- 101000695043 Homo sapiens Serine/threonine-protein kinase BRSK1 Proteins 0.000 description 2
- 101000794043 Homo sapiens Serine/threonine-protein kinase BRSK2 Proteins 0.000 description 2
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 2
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 2
- 101000885321 Homo sapiens Serine/threonine-protein kinase DCLK1 Proteins 0.000 description 2
- 101000885387 Homo sapiens Serine/threonine-protein kinase DCLK2 Proteins 0.000 description 2
- 101000885383 Homo sapiens Serine/threonine-protein kinase DCLK3 Proteins 0.000 description 2
- 101000939549 Homo sapiens Serine/threonine-protein kinase Kist Proteins 0.000 description 2
- 101001047642 Homo sapiens Serine/threonine-protein kinase LATS1 Proteins 0.000 description 2
- 101001047637 Homo sapiens Serine/threonine-protein kinase LATS2 Proteins 0.000 description 2
- 101001038337 Homo sapiens Serine/threonine-protein kinase LMTK1 Proteins 0.000 description 2
- 101001038335 Homo sapiens Serine/threonine-protein kinase LMTK2 Proteins 0.000 description 2
- 101001038341 Homo sapiens Serine/threonine-protein kinase LMTK3 Proteins 0.000 description 2
- 101001059443 Homo sapiens Serine/threonine-protein kinase MARK1 Proteins 0.000 description 2
- 101000576901 Homo sapiens Serine/threonine-protein kinase MRCK alpha Proteins 0.000 description 2
- 101000576904 Homo sapiens Serine/threonine-protein kinase MRCK beta Proteins 0.000 description 2
- 101000576907 Homo sapiens Serine/threonine-protein kinase MRCK gamma Proteins 0.000 description 2
- 101001129076 Homo sapiens Serine/threonine-protein kinase N1 Proteins 0.000 description 2
- 101000691459 Homo sapiens Serine/threonine-protein kinase N2 Proteins 0.000 description 2
- 101000691455 Homo sapiens Serine/threonine-protein kinase N3 Proteins 0.000 description 2
- 101000600885 Homo sapiens Serine/threonine-protein kinase NIM1 Proteins 0.000 description 2
- 101001123846 Homo sapiens Serine/threonine-protein kinase Nek1 Proteins 0.000 description 2
- 101001123812 Homo sapiens Serine/threonine-protein kinase Nek11 Proteins 0.000 description 2
- 101000601441 Homo sapiens Serine/threonine-protein kinase Nek2 Proteins 0.000 description 2
- 101000601456 Homo sapiens Serine/threonine-protein kinase Nek3 Proteins 0.000 description 2
- 101000601460 Homo sapiens Serine/threonine-protein kinase Nek4 Proteins 0.000 description 2
- 101000601467 Homo sapiens Serine/threonine-protein kinase Nek5 Proteins 0.000 description 2
- 101000588540 Homo sapiens Serine/threonine-protein kinase Nek6 Proteins 0.000 description 2
- 101000588545 Homo sapiens Serine/threonine-protein kinase Nek7 Proteins 0.000 description 2
- 101000588548 Homo sapiens Serine/threonine-protein kinase Nek8 Proteins 0.000 description 2
- 101001098464 Homo sapiens Serine/threonine-protein kinase OSR1 Proteins 0.000 description 2
- 101000987310 Homo sapiens Serine/threonine-protein kinase PAK 2 Proteins 0.000 description 2
- 101000987315 Homo sapiens Serine/threonine-protein kinase PAK 3 Proteins 0.000 description 2
- 101000987297 Homo sapiens Serine/threonine-protein kinase PAK 4 Proteins 0.000 description 2
- 101000987295 Homo sapiens Serine/threonine-protein kinase PAK 5 Proteins 0.000 description 2
- 101000605835 Homo sapiens Serine/threonine-protein kinase PINK1, mitochondrial Proteins 0.000 description 2
- 101000729945 Homo sapiens Serine/threonine-protein kinase PLK2 Proteins 0.000 description 2
- 101000691614 Homo sapiens Serine/threonine-protein kinase PLK3 Proteins 0.000 description 2
- 101000582914 Homo sapiens Serine/threonine-protein kinase PLK4 Proteins 0.000 description 2
- 101000756066 Homo sapiens Serine/threonine-protein kinase RIO1 Proteins 0.000 description 2
- 101000754913 Homo sapiens Serine/threonine-protein kinase RIO2 Proteins 0.000 description 2
- 101000754911 Homo sapiens Serine/threonine-protein kinase RIO3 Proteins 0.000 description 2
- 101000693598 Homo sapiens Serine/threonine-protein kinase SBK1 Proteins 0.000 description 2
- 101000693611 Homo sapiens Serine/threonine-protein kinase SBK2 Proteins 0.000 description 2
- 101000709238 Homo sapiens Serine/threonine-protein kinase SIK1 Proteins 0.000 description 2
- 101000709250 Homo sapiens Serine/threonine-protein kinase SIK2 Proteins 0.000 description 2
- 101000654491 Homo sapiens Serine/threonine-protein kinase SIK3 Proteins 0.000 description 2
- 101000864057 Homo sapiens Serine/threonine-protein kinase SMG1 Proteins 0.000 description 2
- 101000628562 Homo sapiens Serine/threonine-protein kinase STK11 Proteins 0.000 description 2
- 101000864800 Homo sapiens Serine/threonine-protein kinase Sgk1 Proteins 0.000 description 2
- 101000864806 Homo sapiens Serine/threonine-protein kinase Sgk2 Proteins 0.000 description 2
- 101000838578 Homo sapiens Serine/threonine-protein kinase TAO2 Proteins 0.000 description 2
- 101000838596 Homo sapiens Serine/threonine-protein kinase TAO3 Proteins 0.000 description 2
- 101000665442 Homo sapiens Serine/threonine-protein kinase TBK1 Proteins 0.000 description 2
- 101000607332 Homo sapiens Serine/threonine-protein kinase ULK2 Proteins 0.000 description 2
- 101000607339 Homo sapiens Serine/threonine-protein kinase ULK3 Proteins 0.000 description 2
- 101000809308 Homo sapiens Serine/threonine-protein kinase ULK4 Proteins 0.000 description 2
- 101000649929 Homo sapiens Serine/threonine-protein kinase VRK1 Proteins 0.000 description 2
- 101000649931 Homo sapiens Serine/threonine-protein kinase VRK2 Proteins 0.000 description 2
- 101000770770 Homo sapiens Serine/threonine-protein kinase WNK1 Proteins 0.000 description 2
- 101000770774 Homo sapiens Serine/threonine-protein kinase WNK2 Proteins 0.000 description 2
- 101000742982 Homo sapiens Serine/threonine-protein kinase WNK3 Proteins 0.000 description 2
- 101000742986 Homo sapiens Serine/threonine-protein kinase WNK4 Proteins 0.000 description 2
- 101000595531 Homo sapiens Serine/threonine-protein kinase pim-1 Proteins 0.000 description 2
- 101001001648 Homo sapiens Serine/threonine-protein kinase pim-2 Proteins 0.000 description 2
- 101001001645 Homo sapiens Serine/threonine-protein kinase pim-3 Proteins 0.000 description 2
- 101000637839 Homo sapiens Serine/threonine-protein kinase tousled-like 1 Proteins 0.000 description 2
- 101000637847 Homo sapiens Serine/threonine-protein kinase tousled-like 2 Proteins 0.000 description 2
- 101000651178 Homo sapiens Striated muscle preferentially expressed protein kinase Proteins 0.000 description 2
- 101000625846 Homo sapiens TBC domain-containing protein kinase-like protein Proteins 0.000 description 2
- 101000662997 Homo sapiens TRAF2 and NCK-interacting protein kinase Proteins 0.000 description 2
- 101000759314 Homo sapiens Tau-tubulin kinase 1 Proteins 0.000 description 2
- 101000759318 Homo sapiens Tau-tubulin kinase 2 Proteins 0.000 description 2
- 101000772239 Homo sapiens Testis-specific serine/threonine-protein kinase 2 Proteins 0.000 description 2
- 101000794197 Homo sapiens Testis-specific serine/threonine-protein kinase 3 Proteins 0.000 description 2
- 101000794199 Homo sapiens Testis-specific serine/threonine-protein kinase 4 Proteins 0.000 description 2
- 101000794200 Homo sapiens Testis-specific serine/threonine-protein kinase 6 Proteins 0.000 description 2
- 101000844519 Homo sapiens Transient receptor potential cation channel subfamily M member 6 Proteins 0.000 description 2
- 101000844518 Homo sapiens Transient receptor potential cation channel subfamily M member 7 Proteins 0.000 description 2
- 101000766349 Homo sapiens Tribbles homolog 2 Proteins 0.000 description 2
- 101000766345 Homo sapiens Tribbles homolog 3 Proteins 0.000 description 2
- 101000823316 Homo sapiens Tyrosine-protein kinase ABL1 Proteins 0.000 description 2
- 101000823271 Homo sapiens Tyrosine-protein kinase ABL2 Proteins 0.000 description 2
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 description 2
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 2
- 101000661459 Homo sapiens Tyrosine-protein kinase STYK1 Proteins 0.000 description 2
- 101000587313 Homo sapiens Tyrosine-protein kinase Srms Proteins 0.000 description 2
- 101000753253 Homo sapiens Tyrosine-protein kinase receptor Tie-1 Proteins 0.000 description 2
- 101001103033 Homo sapiens Tyrosine-protein kinase transmembrane receptor ROR2 Proteins 0.000 description 2
- 101000720059 Homo sapiens Uncharacterized aarF domain-containing protein kinase 2 Proteins 0.000 description 2
- 101000720061 Homo sapiens Uncharacterized aarF domain-containing protein kinase 5 Proteins 0.000 description 2
- 101000693630 Homo sapiens Uncharacterized serine/threonine-protein kinase SBK3 Proteins 0.000 description 2
- 101000621390 Homo sapiens Wee1-like protein kinase Proteins 0.000 description 2
- 101000621401 Homo sapiens Wee1-like protein kinase 2 Proteins 0.000 description 2
- 101000739853 Homo sapiens [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial Proteins 0.000 description 2
- 101001117143 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Proteins 0.000 description 2
- 101000734338 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial Proteins 0.000 description 2
- 101000734339 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Proteins 0.000 description 2
- 101001046426 Homo sapiens cGMP-dependent protein kinase 1 Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102100030266 Inactive serine/threonine-protein kinase PLK5 Human genes 0.000 description 2
- 102100028288 Inactive serine/threonine-protein kinase VRK3 Human genes 0.000 description 2
- 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 2
- 102100034687 Inactive tyrosine-protein kinase PEAK1 Human genes 0.000 description 2
- 102100038659 Inactive tyrosine-protein kinase PRAG1 Human genes 0.000 description 2
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 2
- 102100021854 Inhibitor of nuclear factor kappa-B kinase subunit beta Human genes 0.000 description 2
- 102100021857 Inhibitor of nuclear factor kappa-B kinase subunit epsilon Human genes 0.000 description 2
- 108091006081 Inositol-requiring enzyme-1 Proteins 0.000 description 2
- 102100036721 Insulin receptor Human genes 0.000 description 2
- 102100039137 Insulin receptor-related protein Human genes 0.000 description 2
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
- 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 2
- 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 description 2
- 102100023533 Interleukin-1 receptor-associated kinase 4 Human genes 0.000 description 2
- 102100036433 Interleukin-1 receptor-associated kinase-like 2 Human genes 0.000 description 2
- 102100023093 Kalirin Human genes 0.000 description 2
- 102100021001 Kinase suppressor of Ras 1 Human genes 0.000 description 2
- 102100021000 Kinase suppressor of Ras 2 Human genes 0.000 description 2
- 101150105104 Kras gene Proteins 0.000 description 2
- 239000002176 L01XE26 - Cabozantinib Substances 0.000 description 2
- 102100026023 LIM domain kinase 1 Human genes 0.000 description 2
- 102100021756 LIM domain kinase 2 Human genes 0.000 description 2
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 2
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 102100026299 MAP kinase-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 2
- 102100033610 MAP kinase-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 102100028920 MAP/microtubule affinity-regulating kinase 3 Human genes 0.000 description 2
- 102100028913 MAP/microtubule affinity-regulating kinase 4 Human genes 0.000 description 2
- 101150113964 MPK5 gene Proteins 0.000 description 2
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 2
- 102100021435 Macrophage-stimulating protein receptor Human genes 0.000 description 2
- 102100024299 Maternal embryonic leucine zipper kinase Human genes 0.000 description 2
- 101710154611 Maternal embryonic leucine zipper kinase Proteins 0.000 description 2
- 102100028905 Megakaryocyte-associated tyrosine-protein kinase Human genes 0.000 description 2
- 102100033268 Microtubule-associated serine/threonine-protein kinase 1 Human genes 0.000 description 2
- 102100033253 Microtubule-associated serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 102100033251 Microtubule-associated serine/threonine-protein kinase 3 Human genes 0.000 description 2
- 102100033252 Microtubule-associated serine/threonine-protein kinase 4 Human genes 0.000 description 2
- 102100026287 Misshapen-like kinase 1 Human genes 0.000 description 2
- 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 2
- 102100030177 Mixed lineage kinase domain-like protein Human genes 0.000 description 2
- 101150097381 Mtor gene Proteins 0.000 description 2
- 102100030788 Myosin light chain kinase 2, skeletal/cardiac muscle Human genes 0.000 description 2
- 102100030783 Myosin light chain kinase 3 Human genes 0.000 description 2
- 102100030782 Myosin light chain kinase family member 4 Human genes 0.000 description 2
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 2
- 108010052185 Myotonin-Protein Kinase Proteins 0.000 description 2
- 102100022437 Myotonin-protein kinase Human genes 0.000 description 2
- 102100031703 N-terminal kinase-like protein Human genes 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 102100029166 NT-3 growth factor receptor Human genes 0.000 description 2
- 102100021732 NUAK family SNF1-like kinase 1 Human genes 0.000 description 2
- 102100021733 NUAK family SNF1-like kinase 2 Human genes 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 102100037669 Non-receptor tyrosine-protein kinase TNK1 Human genes 0.000 description 2
- 102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 description 2
- 102100021858 Nuclear receptor-binding protein Human genes 0.000 description 2
- 102100028790 Nuclear receptor-binding protein 2 Human genes 0.000 description 2
- 102100030127 Obscurin Human genes 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 101700056750 PAK1 Proteins 0.000 description 2
- 102100023784 PAN2-PAN3 deadenylation complex subunit PAN3 Human genes 0.000 description 2
- 108010039798 PCTAIRE-3 protein kinase Proteins 0.000 description 2
- 102100032391 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Human genes 0.000 description 2
- 102100030278 Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform Human genes 0.000 description 2
- 108010010522 Phycobilisomes Proteins 0.000 description 2
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 2
- 102100024924 Protein kinase C alpha type Human genes 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- 102100026829 Protein-associating with the carboxyl-terminal domain of ezrin Human genes 0.000 description 2
- 102100037787 Protein-tyrosine kinase 2-beta Human genes 0.000 description 2
- 102100039810 Protein-tyrosine kinase 6 Human genes 0.000 description 2
- 102100023347 Proto-oncogene tyrosine-protein kinase ROS Human genes 0.000 description 2
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 2
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 2
- 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 description 2
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 2
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 2
- 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 2
- 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 2
- 108010079933 Receptor-Interacting Protein Serine-Threonine Kinase 2 Proteins 0.000 description 2
- 102100022501 Receptor-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 2
- 102100022502 Receptor-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 102100033729 Receptor-interacting serine/threonine-protein kinase 3 Human genes 0.000 description 2
- 102100033734 Receptor-interacting serine/threonine-protein kinase 4 Human genes 0.000 description 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 2
- 102100039313 Rho-associated protein kinase 1 Human genes 0.000 description 2
- 102100039314 Rho-associated protein kinase 2 Human genes 0.000 description 2
- 102100031698 SCY1-like protein 2 Human genes 0.000 description 2
- 108091006626 SLC12A7 Proteins 0.000 description 2
- 102100022010 SNF-related serine/threonine-protein kinase Human genes 0.000 description 2
- 102000001332 SRC Human genes 0.000 description 2
- 108060006706 SRC Proteins 0.000 description 2
- 102100023010 SRSF protein kinase 1 Human genes 0.000 description 2
- 102100023015 SRSF protein kinase 2 Human genes 0.000 description 2
- 102100023017 SRSF protein kinase 3 Human genes 0.000 description 2
- 102100030491 STE20/SPS1-related proline-alanine-rich protein kinase Human genes 0.000 description 2
- 102100026758 Serine/threonine-protein kinase 16 Human genes 0.000 description 2
- 102100026737 Serine/threonine-protein kinase 25 Human genes 0.000 description 2
- 102100030617 Serine/threonine-protein kinase 26 Human genes 0.000 description 2
- 102100030618 Serine/threonine-protein kinase 31 Human genes 0.000 description 2
- 102100030515 Serine/threonine-protein kinase 33 Human genes 0.000 description 2
- 102100030620 Serine/threonine-protein kinase 35 Human genes 0.000 description 2
- 102100030513 Serine/threonine-protein kinase 36 Human genes 0.000 description 2
- 102100030514 Serine/threonine-protein kinase 38 Human genes 0.000 description 2
- 102100037629 Serine/threonine-protein kinase 4 Human genes 0.000 description 2
- 102100037627 Serine/threonine-protein kinase 40 Human genes 0.000 description 2
- 102100029437 Serine/threonine-protein kinase A-Raf Human genes 0.000 description 2
- 102100028623 Serine/threonine-protein kinase BRSK1 Human genes 0.000 description 2
- 102100029891 Serine/threonine-protein kinase BRSK2 Human genes 0.000 description 2
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 2
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 2
- 102100039758 Serine/threonine-protein kinase DCLK1 Human genes 0.000 description 2
- 102100039775 Serine/threonine-protein kinase DCLK2 Human genes 0.000 description 2
- 102100039774 Serine/threonine-protein kinase DCLK3 Human genes 0.000 description 2
- 102100029680 Serine/threonine-protein kinase Kist Human genes 0.000 description 2
- 102100024031 Serine/threonine-protein kinase LATS1 Human genes 0.000 description 2
- 102100024043 Serine/threonine-protein kinase LATS2 Human genes 0.000 description 2
- 102100040293 Serine/threonine-protein kinase LMTK1 Human genes 0.000 description 2
- 102100040292 Serine/threonine-protein kinase LMTK2 Human genes 0.000 description 2
- 102100040291 Serine/threonine-protein kinase LMTK3 Human genes 0.000 description 2
- 102100028921 Serine/threonine-protein kinase MARK1 Human genes 0.000 description 2
- 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 description 2
- 102100025347 Serine/threonine-protein kinase MRCK beta Human genes 0.000 description 2
- 102100025345 Serine/threonine-protein kinase MRCK gamma Human genes 0.000 description 2
- 102100026180 Serine/threonine-protein kinase N2 Human genes 0.000 description 2
- 102100026219 Serine/threonine-protein kinase N3 Human genes 0.000 description 2
- 102100037345 Serine/threonine-protein kinase NIM1 Human genes 0.000 description 2
- 102100028751 Serine/threonine-protein kinase Nek1 Human genes 0.000 description 2
- 102100028775 Serine/threonine-protein kinase Nek11 Human genes 0.000 description 2
- 102100037703 Serine/threonine-protein kinase Nek2 Human genes 0.000 description 2
- 102100037706 Serine/threonine-protein kinase Nek3 Human genes 0.000 description 2
- 102100037705 Serine/threonine-protein kinase Nek4 Human genes 0.000 description 2
- 102100037702 Serine/threonine-protein kinase Nek5 Human genes 0.000 description 2
- 102100031401 Serine/threonine-protein kinase Nek6 Human genes 0.000 description 2
- 102100031400 Serine/threonine-protein kinase Nek7 Human genes 0.000 description 2
- 102100037143 Serine/threonine-protein kinase OSR1 Human genes 0.000 description 2
- 102100027939 Serine/threonine-protein kinase PAK 2 Human genes 0.000 description 2
- 102100027911 Serine/threonine-protein kinase PAK 3 Human genes 0.000 description 2
- 102100027940 Serine/threonine-protein kinase PAK 4 Human genes 0.000 description 2
- 102100038376 Serine/threonine-protein kinase PINK1, mitochondrial Human genes 0.000 description 2
- 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 description 2
- 102100031462 Serine/threonine-protein kinase PLK2 Human genes 0.000 description 2
- 102100026209 Serine/threonine-protein kinase PLK3 Human genes 0.000 description 2
- 102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 2
- 102100022261 Serine/threonine-protein kinase RIO1 Human genes 0.000 description 2
- 102100022090 Serine/threonine-protein kinase RIO2 Human genes 0.000 description 2
- 102100022109 Serine/threonine-protein kinase RIO3 Human genes 0.000 description 2
- 102100025554 Serine/threonine-protein kinase SBK1 Human genes 0.000 description 2
- 102100025559 Serine/threonine-protein kinase SBK2 Human genes 0.000 description 2
- 102100032771 Serine/threonine-protein kinase SIK1 Human genes 0.000 description 2
- 102100034377 Serine/threonine-protein kinase SIK2 Human genes 0.000 description 2
- 102100031445 Serine/threonine-protein kinase SIK3 Human genes 0.000 description 2
- 102100029938 Serine/threonine-protein kinase SMG1 Human genes 0.000 description 2
- 102100026715 Serine/threonine-protein kinase STK11 Human genes 0.000 description 2
- 102100030070 Serine/threonine-protein kinase Sgk1 Human genes 0.000 description 2
- 102100028948 Serine/threonine-protein kinase TAO1 Human genes 0.000 description 2
- 101710106079 Serine/threonine-protein kinase TAO1 Proteins 0.000 description 2
- 102100028949 Serine/threonine-protein kinase TAO2 Human genes 0.000 description 2
- 102100028954 Serine/threonine-protein kinase TAO3 Human genes 0.000 description 2
- 102100038192 Serine/threonine-protein kinase TBK1 Human genes 0.000 description 2
- 102100039988 Serine/threonine-protein kinase ULK1 Human genes 0.000 description 2
- 102100039987 Serine/threonine-protein kinase ULK2 Human genes 0.000 description 2
- 102100039985 Serine/threonine-protein kinase ULK3 Human genes 0.000 description 2
- 102100038455 Serine/threonine-protein kinase ULK4 Human genes 0.000 description 2
- 102100028235 Serine/threonine-protein kinase VRK1 Human genes 0.000 description 2
- 102100028234 Serine/threonine-protein kinase VRK2 Human genes 0.000 description 2
- 102100029064 Serine/threonine-protein kinase WNK1 Human genes 0.000 description 2
- 102100029063 Serine/threonine-protein kinase WNK2 Human genes 0.000 description 2
- 102100038115 Serine/threonine-protein kinase WNK3 Human genes 0.000 description 2
- 102100038101 Serine/threonine-protein kinase WNK4 Human genes 0.000 description 2
- 102100039278 Serine/threonine-protein kinase greatwall Human genes 0.000 description 2
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
- 102100036077 Serine/threonine-protein kinase pim-1 Human genes 0.000 description 2
- 102100036120 Serine/threonine-protein kinase pim-2 Human genes 0.000 description 2
- 102100036119 Serine/threonine-protein kinase pim-3 Human genes 0.000 description 2
- 102100032015 Serine/threonine-protein kinase tousled-like 1 Human genes 0.000 description 2
- 102100032014 Serine/threonine-protein kinase tousled-like 2 Human genes 0.000 description 2
- 102100034252 Solute carrier family 12 member 7 Human genes 0.000 description 2
- 102100027659 Striated muscle preferentially expressed protein kinase Human genes 0.000 description 2
- 102100024750 TBC domain-containing protein kinase-like protein Human genes 0.000 description 2
- 102100037671 TRAF2 and NCK-interacting protein kinase Human genes 0.000 description 2
- 102000003608 TRPM6 Human genes 0.000 description 2
- 102000003611 TRPM7 Human genes 0.000 description 2
- 102100023277 Tau-tubulin kinase 1 Human genes 0.000 description 2
- 102100023276 Tau-tubulin kinase 2 Human genes 0.000 description 2
- 102100029355 Testis-specific serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 102100030168 Testis-specific serine/threonine-protein kinase 3 Human genes 0.000 description 2
- 102100030167 Testis-specific serine/threonine-protein kinase 4 Human genes 0.000 description 2
- 102100030141 Testis-specific serine/threonine-protein kinase 6 Human genes 0.000 description 2
- 102100026260 Titin Human genes 0.000 description 2
- 102100026394 Tribbles homolog 2 Human genes 0.000 description 2
- 102100026390 Tribbles homolog 3 Human genes 0.000 description 2
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 2
- 102100022651 Tyrosine-protein kinase ABL2 Human genes 0.000 description 2
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 description 2
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 2
- 102100022356 Tyrosine-protein kinase Mer Human genes 0.000 description 2
- 102100037781 Tyrosine-protein kinase STYK1 Human genes 0.000 description 2
- 102100029654 Tyrosine-protein kinase Srms Human genes 0.000 description 2
- 102100022007 Tyrosine-protein kinase receptor Tie-1 Human genes 0.000 description 2
- 102100039616 Tyrosine-protein kinase transmembrane receptor ROR2 Human genes 0.000 description 2
- 102100025993 Uncharacterized aarF domain-containing protein kinase 2 Human genes 0.000 description 2
- 102100025996 Uncharacterized aarF domain-containing protein kinase 5 Human genes 0.000 description 2
- 102100025558 Uncharacterized serine/threonine-protein kinase SBK3 Human genes 0.000 description 2
- 102100023037 Wee1-like protein kinase Human genes 0.000 description 2
- 102100023040 Wee1-like protein kinase 2 Human genes 0.000 description 2
- 102100037607 [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial Human genes 0.000 description 2
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 2
- 102100024150 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Human genes 0.000 description 2
- 102100034824 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial Human genes 0.000 description 2
- 102100034825 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Human genes 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- BGLGAKMTYHWWKW-UHFFFAOYSA-N acridine yellow Chemical compound [H+].[Cl-].CC1=C(N)C=C2N=C(C=C(C(C)=C3)N)C3=CC2=C1 BGLGAKMTYHWWKW-UHFFFAOYSA-N 0.000 description 2
- 150000001251 acridines Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 229940027998 antiseptic and disinfectant acridine derivative Drugs 0.000 description 2
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 238000006664 bond formation reaction Methods 0.000 description 2
- 108010018804 c-Mer Tyrosine Kinase Proteins 0.000 description 2
- 102100029402 cAMP-dependent protein kinase catalytic subunit PRKX Human genes 0.000 description 2
- 102100022422 cGMP-dependent protein kinase 1 Human genes 0.000 description 2
- 229960001292 cabozantinib Drugs 0.000 description 2
- ONIQOQHATWINJY-UHFFFAOYSA-N cabozantinib Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C1(C(=O)NC=2C=CC(F)=CC=2)CC1 ONIQOQHATWINJY-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 2
- 230000005754 cellular signaling Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 108010054372 insulin receptor-related receptor Proteins 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 2
- 229940107698 malachite green Drugs 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002159 nanocrystal Substances 0.000 description 2
- 150000002790 naphthalenes Chemical class 0.000 description 2
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 2
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000004866 oxadiazoles Chemical class 0.000 description 2
- GHTWDWCFRFTBRB-UHFFFAOYSA-M oxazine-170 Chemical compound [O-]Cl(=O)(=O)=O.N1=C2C3=CC=CC=C3C(NCC)=CC2=[O+]C2=C1C=C(C)C(N(C)CC)=C2 GHTWDWCFRFTBRB-UHFFFAOYSA-M 0.000 description 2
- 150000004893 oxazines Chemical class 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 210000002306 phycobilisome Anatomy 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 108010056274 polo-like kinase 1 Proteins 0.000 description 2
- RKCAIXNGYQCCAL-UHFFFAOYSA-N porphin Chemical compound N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 RKCAIXNGYQCCAL-UHFFFAOYSA-N 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 229960000286 proflavine Drugs 0.000 description 2
- 150000003220 pyrenes Chemical class 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 102000016914 ras Proteins Human genes 0.000 description 2
- 108010054624 red fluorescent protein Proteins 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000001945 resonance Rayleigh scattering spectroscopy Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 102200006531 rs121913529 Human genes 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 108010064892 trkC Receptor Proteins 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- DWYRIWUZIJHQKQ-SANMLTNESA-N (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine Chemical compound Cn1cc(cn1)-c1cc2c(ncnn2c1)N1CCN(CC1)c1ncc(cn1)[C@@](C)(N)c1ccc(F)cc1 DWYRIWUZIJHQKQ-SANMLTNESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- NYNZQNWKBKUAII-KBXCAEBGSA-N (3s)-n-[5-[(2r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C1[C@@H](O)CCN1C(=O)NC1=C2N=C(N3[C@H](CCC3)C=3C(=CC=C(F)C=3)F)C=CN2N=C1 NYNZQNWKBKUAII-KBXCAEBGSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- BIJNHUAPTJVVNQ-UHFFFAOYSA-N 1-Hydroxypyrene Chemical compound C1=C2C(O)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 BIJNHUAPTJVVNQ-UHFFFAOYSA-N 0.000 description 1
- 102000001556 1-Phosphatidylinositol 4-Kinase Human genes 0.000 description 1
- 150000004782 1-naphthols Chemical class 0.000 description 1
- XWNJMSJGJFSGRY-UHFFFAOYSA-N 2-(benzylamino)-3,7-dihydropurin-6-one Chemical group N1C=2N=CNC=2C(=O)N=C1NCC1=CC=CC=C1 XWNJMSJGJFSGRY-UHFFFAOYSA-N 0.000 description 1
- 102100027962 2-5A-dependent ribonuclease Human genes 0.000 description 1
- UCSBOFLEOACXIR-UHFFFAOYSA-N 2-benzyl-8-(cyclopentylmethyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-ol Chemical compound Oc1c(Cc2ccccc2)nc2c(CC3CCCC3)nc(cn12)-c1ccc(O)cc1 UCSBOFLEOACXIR-UHFFFAOYSA-N 0.000 description 1
- IPFDTWHBEBJTLE-UHFFFAOYSA-N 2h-acridin-1-one Chemical class C1=CC=C2C=C3C(=O)CC=CC3=NC2=C1 IPFDTWHBEBJTLE-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- WHSOKGZCVSCOJM-UHFFFAOYSA-N 4-amino-1-benzylpyrimidin-2-one Chemical group O=C1N=C(N)C=CN1CC1=CC=CC=C1 WHSOKGZCVSCOJM-UHFFFAOYSA-N 0.000 description 1
- 102100022528 5'-AMP-activated protein kinase catalytic subunit alpha-1 Human genes 0.000 description 1
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 1
- AILRADAXUVEEIR-UHFFFAOYSA-N 5-chloro-4-n-(2-dimethylphosphorylphenyl)-2-n-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine Chemical compound COC1=CC(N2CCC(CC2)N2CCN(C)CC2)=CC=C1NC(N=1)=NC=C(Cl)C=1NC1=CC=CC=C1P(C)(C)=O AILRADAXUVEEIR-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- RRHXPUCIXLAHIY-UHFFFAOYSA-N 7-aminochromen-2-one Chemical compound C1=CC(=O)OC2=CC(N)=CC=C21 RRHXPUCIXLAHIY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- WJOLQGAMGUBOFS-UHFFFAOYSA-N 8-(cyclopentylmethyl)-2-[(4-fluorophenyl)methyl]-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-ol Chemical compound Oc1c(Cc2ccc(F)cc2)nc2c(CC3CCCC3)nc(cn12)-c1ccc(O)cc1 WJOLQGAMGUBOFS-UHFFFAOYSA-N 0.000 description 1
- YBLMZJSGNQTCLU-UHFFFAOYSA-N 8-(cyclopentylmethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]imidazo[1,2-a]pyrazin-3-ol Chemical compound Oc1c(Cc2ccc(O)cc2)nc2c(CC3CCCC3)nc(cn12)-c1ccc(O)cc1 YBLMZJSGNQTCLU-UHFFFAOYSA-N 0.000 description 1
- MEMQQZHHXCOKGG-UHFFFAOYSA-N 8-benzyl-2-[(4-fluorophenyl)methyl]-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-ol Chemical compound Oc1c(Cc2ccc(F)cc2)nc2c(Cc3ccccc3)nc(cn12)-c1ccc(O)cc1 MEMQQZHHXCOKGG-UHFFFAOYSA-N 0.000 description 1
- ONVKEAHBFKWZHK-UHFFFAOYSA-N 8-benzyl-6-(4-hydroxyphenyl)-2-(naphthalen-1-ylmethyl)imidazo[1,2-a]pyrazin-3-ol Chemical compound Oc1c(Cc2cccc3ccccc23)nc2c(Cc3ccccc3)nc(cn12)-c1ccc(O)cc1 ONVKEAHBFKWZHK-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102000042564 AGC Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091053408 AGC Ser/Thr protein kinase family Proteins 0.000 description 1
- 102100034134 Activin receptor type-1B Human genes 0.000 description 1
- 102100034135 Activin receptor type-1C Human genes 0.000 description 1
- 102100021886 Activin receptor type-2A Human genes 0.000 description 1
- 102100027647 Activin receptor type-2B Human genes 0.000 description 1
- 102000042857 Alpha-type protein kinase family Human genes 0.000 description 1
- 108091082204 Alpha-type protein kinase family Proteins 0.000 description 1
- 101000995861 Arabidopsis thaliana Regulatory protein NPR1 Proteins 0.000 description 1
- 101100150619 Arabidopsis thaliana STKL1 gene Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
- 101100381860 Bacillus subtilis (strain 168) bmr gene Proteins 0.000 description 1
- 101100061527 Bacillus subtilis (strain 168) csk22 gene Proteins 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 102100021738 Beta-adrenergic receptor kinase 1 Human genes 0.000 description 1
- 102100037281 Beta-adrenergic receptor kinase 2 Human genes 0.000 description 1
- 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 description 1
- 102100027052 Bone morphogenetic protein receptor type-1B Human genes 0.000 description 1
- 102000042856 CAMK Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091082193 CAMK Ser/Thr protein kinase family Proteins 0.000 description 1
- 108091007914 CDKs Proteins 0.000 description 1
- 102000043135 CK1 Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091054457 CK1 Ser/Thr protein kinase family Proteins 0.000 description 1
- 102000042858 CMGC Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091082290 CMGC Ser/Thr protein kinase family Proteins 0.000 description 1
- 101100322915 Caenorhabditis elegans akt-1 gene Proteins 0.000 description 1
- 101100220147 Caenorhabditis elegans cdkl-1 gene Proteins 0.000 description 1
- 102100021535 Calcium/calmodulin-dependent protein kinase kinase 1 Human genes 0.000 description 1
- 102100021534 Calcium/calmodulin-dependent protein kinase kinase 2 Human genes 0.000 description 1
- 102100033086 Calcium/calmodulin-dependent protein kinase type 1 Human genes 0.000 description 1
- 102100033087 Calcium/calmodulin-dependent protein kinase type 1B Human genes 0.000 description 1
- 102100033088 Calcium/calmodulin-dependent protein kinase type 1D Human genes 0.000 description 1
- 102100033089 Calcium/calmodulin-dependent protein kinase type 1G Human genes 0.000 description 1
- 102100033093 Calcium/calmodulin-dependent protein kinase type II subunit alpha Human genes 0.000 description 1
- 102100025232 Calcium/calmodulin-dependent protein kinase type II subunit beta Human genes 0.000 description 1
- 102100025228 Calcium/calmodulin-dependent protein kinase type II subunit delta Human genes 0.000 description 1
- 102100022789 Calcium/calmodulin-dependent protein kinase type IV Human genes 0.000 description 1
- 108030005456 Calcium/calmodulin-dependent protein kinases Proteins 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 101100400867 Candida albicans (strain SC5314 / ATCC MYA-2876) MDR1 gene Proteins 0.000 description 1
- 102000008122 Casein Kinase I Human genes 0.000 description 1
- 108010049812 Casein Kinase I Proteins 0.000 description 1
- 102100034357 Casein kinase I isoform alpha Human genes 0.000 description 1
- 102100034356 Casein kinase I isoform alpha-like Human genes 0.000 description 1
- 102100037402 Casein kinase I isoform delta Human genes 0.000 description 1
- 102100037398 Casein kinase I isoform epsilon Human genes 0.000 description 1
- 102100037397 Casein kinase I isoform gamma-1 Human genes 0.000 description 1
- 102100023060 Casein kinase I isoform gamma-2 Human genes 0.000 description 1
- 102100023067 Casein kinase I isoform gamma-3 Human genes 0.000 description 1
- 102100027808 Casein kinase II subunit alpha 3 Human genes 0.000 description 1
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 108010002947 Connectin Proteins 0.000 description 1
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
- 102100037912 Cyclin-dependent kinase 11A Human genes 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
- 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 101100108136 Drosophila melanogaster Adck1 gene Proteins 0.000 description 1
- 102100029638 Dual serine/threonine and tyrosine protein kinase Human genes 0.000 description 1
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
- 102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 description 1
- 102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 description 1
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 1
- 102100023272 Dual specificity mitogen-activated protein kinase kinase 5 Human genes 0.000 description 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 1
- 102100023332 Dual specificity mitogen-activated protein kinase kinase 7 Human genes 0.000 description 1
- 102100028554 Dual specificity tyrosine-phosphorylation-regulated kinase 1A Human genes 0.000 description 1
- 102100033363 Dual specificity tyrosine-phosphorylation-regulated kinase 1B Human genes 0.000 description 1
- 108030004793 Dual-specificity kinases Proteins 0.000 description 1
- 102100021600 Ephrin type-A receptor 10 Human genes 0.000 description 1
- 102100021808 Eukaryotic elongation factor 2 kinase Human genes 0.000 description 1
- 102100034174 Eukaryotic translation initiation factor 2-alpha kinase 3 Human genes 0.000 description 1
- 108091071510 FAST protein kinase family Proteins 0.000 description 1
- 102000040800 FAST protein kinase family Human genes 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 108091005973 GFP derivatives Proteins 0.000 description 1
- 102000001267 GSK3 Human genes 0.000 description 1
- 108060006662 GSK3 Proteins 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- 108010078321 Guanylate Cyclase Proteins 0.000 description 1
- 102000014469 Guanylate cyclase Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001080057 Homo sapiens 2-5A-dependent ribonuclease Proteins 0.000 description 1
- 101000677993 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-1 Proteins 0.000 description 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
- 101000799189 Homo sapiens Activin receptor type-1B Proteins 0.000 description 1
- 101000799193 Homo sapiens Activin receptor type-1C Proteins 0.000 description 1
- 101000970954 Homo sapiens Activin receptor type-2A Proteins 0.000 description 1
- 101000937269 Homo sapiens Activin receptor type-2B Proteins 0.000 description 1
- 101000751445 Homo sapiens Beta-adrenergic receptor kinase 1 Proteins 0.000 description 1
- 101000806653 Homo sapiens Beta-adrenergic receptor kinase 2 Proteins 0.000 description 1
- 101000934638 Homo sapiens Bone morphogenetic protein receptor type-1A Proteins 0.000 description 1
- 101000984546 Homo sapiens Bone morphogenetic protein receptor type-1B Proteins 0.000 description 1
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
- 101100287682 Homo sapiens CAMK2G gene Proteins 0.000 description 1
- 101100126883 Homo sapiens CAMK4 gene Proteins 0.000 description 1
- 101100113690 Homo sapiens CLK1 gene Proteins 0.000 description 1
- 101000971625 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 1 Proteins 0.000 description 1
- 101000971617 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 2 Proteins 0.000 description 1
- 101000944250 Homo sapiens Calcium/calmodulin-dependent protein kinase type 1 Proteins 0.000 description 1
- 101000944254 Homo sapiens Calcium/calmodulin-dependent protein kinase type 1B Proteins 0.000 description 1
- 101000944258 Homo sapiens Calcium/calmodulin-dependent protein kinase type 1D Proteins 0.000 description 1
- 101000944259 Homo sapiens Calcium/calmodulin-dependent protein kinase type 1G Proteins 0.000 description 1
- 101000944249 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit alpha Proteins 0.000 description 1
- 101001077352 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit beta Proteins 0.000 description 1
- 101001077338 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit delta Proteins 0.000 description 1
- 101001077334 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit gamma Proteins 0.000 description 1
- 101000974816 Homo sapiens Calcium/calmodulin-dependent protein kinase type IV Proteins 0.000 description 1
- 101000994700 Homo sapiens Casein kinase I isoform alpha Proteins 0.000 description 1
- 101000994694 Homo sapiens Casein kinase I isoform alpha-like Proteins 0.000 description 1
- 101001026336 Homo sapiens Casein kinase I isoform delta Proteins 0.000 description 1
- 101001026376 Homo sapiens Casein kinase I isoform epsilon Proteins 0.000 description 1
- 101001026384 Homo sapiens Casein kinase I isoform gamma-1 Proteins 0.000 description 1
- 101001049881 Homo sapiens Casein kinase I isoform gamma-2 Proteins 0.000 description 1
- 101001049879 Homo sapiens Casein kinase I isoform gamma-3 Proteins 0.000 description 1
- 101000892026 Homo sapiens Casein kinase II subunit alpha Proteins 0.000 description 1
- 101000859996 Homo sapiens Casein kinase II subunit alpha 3 Proteins 0.000 description 1
- 101000738403 Homo sapiens Cyclin-dependent kinase 11A Proteins 0.000 description 1
- 101000865739 Homo sapiens Dual serine/threonine and tyrosine protein kinase Proteins 0.000 description 1
- 101001115394 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 3 Proteins 0.000 description 1
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 1
- 101000624594 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 7 Proteins 0.000 description 1
- 101000838016 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 1A Proteins 0.000 description 1
- 101000926738 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 1B Proteins 0.000 description 1
- 101000898673 Homo sapiens Ephrin type-A receptor 10 Proteins 0.000 description 1
- 101000895759 Homo sapiens Eukaryotic elongation factor 2 kinase Proteins 0.000 description 1
- 101000926530 Homo sapiens Eukaryotic translation initiation factor 2-alpha kinase 1 Proteins 0.000 description 1
- 101000926508 Homo sapiens Eukaryotic translation initiation factor 2-alpha kinase 3 Proteins 0.000 description 1
- 101000889893 Homo sapiens Inactive serine/threonine-protein kinase TEX14 Proteins 0.000 description 1
- 101001043764 Homo sapiens Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 1
- 101001043761 Homo sapiens Inhibitor of nuclear factor kappa-B kinase subunit epsilon Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 101000762967 Homo sapiens Lymphokine-activated killer T-cell-originated protein kinase Proteins 0.000 description 1
- 101000687968 Homo sapiens Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Proteins 0.000 description 1
- 101000628949 Homo sapiens Mitogen-activated protein kinase 10 Proteins 0.000 description 1
- 101000628967 Homo sapiens Mitogen-activated protein kinase 11 Proteins 0.000 description 1
- 101000628954 Homo sapiens Mitogen-activated protein kinase 12 Proteins 0.000 description 1
- 101000628968 Homo sapiens Mitogen-activated protein kinase 13 Proteins 0.000 description 1
- 101000976899 Homo sapiens Mitogen-activated protein kinase 15 Proteins 0.000 description 1
- 101001052477 Homo sapiens Mitogen-activated protein kinase 4 Proteins 0.000 description 1
- 101000950710 Homo sapiens Mitogen-activated protein kinase 6 Proteins 0.000 description 1
- 101000950687 Homo sapiens Mitogen-activated protein kinase 7 Proteins 0.000 description 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 1
- 101000958409 Homo sapiens Mitogen-activated protein kinase kinase kinase 10 Proteins 0.000 description 1
- 101001005602 Homo sapiens Mitogen-activated protein kinase kinase kinase 11 Proteins 0.000 description 1
- 101001005605 Homo sapiens Mitogen-activated protein kinase kinase kinase 12 Proteins 0.000 description 1
- 101001005609 Homo sapiens Mitogen-activated protein kinase kinase kinase 13 Proteins 0.000 description 1
- 101001005550 Homo sapiens Mitogen-activated protein kinase kinase kinase 14 Proteins 0.000 description 1
- 101001005552 Homo sapiens Mitogen-activated protein kinase kinase kinase 15 Proteins 0.000 description 1
- 101001005556 Homo sapiens Mitogen-activated protein kinase kinase kinase 19 Proteins 0.000 description 1
- 101001018141 Homo sapiens Mitogen-activated protein kinase kinase kinase 2 Proteins 0.000 description 1
- 101001018157 Homo sapiens Mitogen-activated protein kinase kinase kinase 20 Proteins 0.000 description 1
- 101001018149 Homo sapiens Mitogen-activated protein kinase kinase kinase 21 Proteins 0.000 description 1
- 101001018145 Homo sapiens Mitogen-activated protein kinase kinase kinase 3 Proteins 0.000 description 1
- 101001018147 Homo sapiens Mitogen-activated protein kinase kinase kinase 4 Proteins 0.000 description 1
- 101001018196 Homo sapiens Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 1
- 101001055097 Homo sapiens Mitogen-activated protein kinase kinase kinase 6 Proteins 0.000 description 1
- 101001055092 Homo sapiens Mitogen-activated protein kinase kinase kinase 7 Proteins 0.000 description 1
- 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
- 101001055085 Homo sapiens Mitogen-activated protein kinase kinase kinase 9 Proteins 0.000 description 1
- 101001059991 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 1 Proteins 0.000 description 1
- 101001059990 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 2 Proteins 0.000 description 1
- 101001059989 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 3 Proteins 0.000 description 1
- 101001059984 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 4 Proteins 0.000 description 1
- 101001059982 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 5 Proteins 0.000 description 1
- 101000794228 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Proteins 0.000 description 1
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 1
- 101000595751 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Proteins 0.000 description 1
- 101000692672 Homo sapiens Phosphoinositide 3-kinase regulatory subunit 4 Proteins 0.000 description 1
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 1
- 101001051777 Homo sapiens Protein kinase C alpha type Proteins 0.000 description 1
- 101001051767 Homo sapiens Protein kinase C beta type Proteins 0.000 description 1
- 101001026854 Homo sapiens Protein kinase C delta type Proteins 0.000 description 1
- 101001026852 Homo sapiens Protein kinase C epsilon type Proteins 0.000 description 1
- 101000971400 Homo sapiens Protein kinase C eta type Proteins 0.000 description 1
- 101000971404 Homo sapiens Protein kinase C iota type Proteins 0.000 description 1
- 101000971468 Homo sapiens Protein kinase C zeta type Proteins 0.000 description 1
- 101001125116 Homo sapiens Putative serine/threonine-protein kinase PRKY Proteins 0.000 description 1
- 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
- 101100181207 Homo sapiens RSKR gene Proteins 0.000 description 1
- 101000829506 Homo sapiens Rhodopsin kinase GRK1 Proteins 0.000 description 1
- 101000871032 Homo sapiens Rhodopsin kinase GRK7 Proteins 0.000 description 1
- 101000944909 Homo sapiens Ribosomal protein S6 kinase alpha-1 Proteins 0.000 description 1
- 101000944921 Homo sapiens Ribosomal protein S6 kinase alpha-2 Proteins 0.000 description 1
- 101000945090 Homo sapiens Ribosomal protein S6 kinase alpha-3 Proteins 0.000 description 1
- 101000945093 Homo sapiens Ribosomal protein S6 kinase alpha-4 Proteins 0.000 description 1
- 101000945096 Homo sapiens Ribosomal protein S6 kinase alpha-5 Proteins 0.000 description 1
- 101001051723 Homo sapiens Ribosomal protein S6 kinase alpha-6 Proteins 0.000 description 1
- 101001051706 Homo sapiens Ribosomal protein S6 kinase beta-1 Proteins 0.000 description 1
- 101001051714 Homo sapiens Ribosomal protein S6 kinase beta-2 Proteins 0.000 description 1
- 101001051707 Homo sapiens Ribosomal protein S6 kinase delta-1 Proteins 0.000 description 1
- 101000726974 Homo sapiens Ribosomal protein S6 kinase-like 1 Proteins 0.000 description 1
- 101000642656 Homo sapiens STE20-related kinase adapter protein beta Proteins 0.000 description 1
- 101000585262 Homo sapiens Serine/threonine kinase-like domain-containing protein STKLD1 Proteins 0.000 description 1
- 101000648174 Homo sapiens Serine/threonine-protein kinase 10 Proteins 0.000 description 1
- 101000661821 Homo sapiens Serine/threonine-protein kinase 17A Proteins 0.000 description 1
- 101000661819 Homo sapiens Serine/threonine-protein kinase 17B Proteins 0.000 description 1
- 101000697591 Homo sapiens Serine/threonine-protein kinase 32A Proteins 0.000 description 1
- 101000697600 Homo sapiens Serine/threonine-protein kinase 32B Proteins 0.000 description 1
- 101000697610 Homo sapiens Serine/threonine-protein kinase 32C Proteins 0.000 description 1
- 101000697608 Homo sapiens Serine/threonine-protein kinase 38-like Proteins 0.000 description 1
- 101001026870 Homo sapiens Serine/threonine-protein kinase D1 Proteins 0.000 description 1
- 101001026885 Homo sapiens Serine/threonine-protein kinase D3 Proteins 0.000 description 1
- 101001006988 Homo sapiens Serine/threonine-protein kinase H2 Proteins 0.000 description 1
- 101001123814 Homo sapiens Serine/threonine-protein kinase Nek10 Proteins 0.000 description 1
- 101001117150 Homo sapiens Serine/threonine-protein kinase PDIK1L Proteins 0.000 description 1
- 101000577652 Homo sapiens Serine/threonine-protein kinase PRP4 homolog Proteins 0.000 description 1
- 101000662993 Homo sapiens Serine/threonine-protein kinase TNNI3K Proteins 0.000 description 1
- 101001036145 Homo sapiens Serine/threonine-protein kinase greatwall Proteins 0.000 description 1
- 101000989953 Homo sapiens Serine/threonine-protein kinase haspin Proteins 0.000 description 1
- 101100245176 Homo sapiens TP53RK gene Proteins 0.000 description 1
- 101000772231 Homo sapiens Testis-specific serine/threonine-protein kinase 1 Proteins 0.000 description 1
- 101000766332 Homo sapiens Tribbles homolog 1 Proteins 0.000 description 1
- 101000820294 Homo sapiens Tyrosine-protein kinase Yes Proteins 0.000 description 1
- 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 description 1
- 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 1
- 101000994496 Homo sapiens cAMP-dependent protein kinase catalytic subunit alpha Proteins 0.000 description 1
- 101000944219 Homo sapiens cAMP-dependent protein kinase catalytic subunit beta Proteins 0.000 description 1
- 101000944207 Homo sapiens cAMP-dependent protein kinase catalytic subunit gamma Proteins 0.000 description 1
- 101001046427 Homo sapiens cGMP-dependent protein kinase 2 Proteins 0.000 description 1
- 101000926525 Homo sapiens eIF-2-alpha kinase GCN2 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 102100040173 Inactive serine/threonine-protein kinase TEX14 Human genes 0.000 description 1
- 102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 239000002147 L01XE04 - Sunitinib Substances 0.000 description 1
- 239000005511 L01XE05 - Sorafenib Substances 0.000 description 1
- 239000002118 L01XE12 - Vandetanib Substances 0.000 description 1
- 239000002146 L01XE16 - Crizotinib Substances 0.000 description 1
- 239000002144 L01XE18 - Ruxolitinib Substances 0.000 description 1
- 239000002138 L01XE21 - Regorafenib Substances 0.000 description 1
- 239000002137 L01XE24 - Ponatinib Substances 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 102100026753 Lymphokine-activated killer T-cell-originated protein kinase Human genes 0.000 description 1
- 108010068342 MAP Kinase Kinase 1 Proteins 0.000 description 1
- 108010068353 MAP Kinase Kinase 2 Proteins 0.000 description 1
- 108010068305 MAP Kinase Kinase 5 Proteins 0.000 description 1
- 108010075654 MAP Kinase Kinase Kinase 1 Proteins 0.000 description 1
- 102100034069 MAP kinase-activated protein kinase 2 Human genes 0.000 description 1
- 102100028397 MAP kinase-activated protein kinase 3 Human genes 0.000 description 1
- 102100028396 MAP kinase-activated protein kinase 5 Human genes 0.000 description 1
- 108010041955 MAP-kinase-activated kinase 2 Proteins 0.000 description 1
- 108010041980 MAP-kinase-activated kinase 3 Proteins 0.000 description 1
- 108010041164 MAP-kinase-activated kinase 5 Proteins 0.000 description 1
- 108700012928 MAPK14 Proteins 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 101150003941 Mapk14 gene Proteins 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 102100024262 Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 description 1
- 102100026929 Mitogen-activated protein kinase 11 Human genes 0.000 description 1
- 102100026932 Mitogen-activated protein kinase 12 Human genes 0.000 description 1
- 102100026930 Mitogen-activated protein kinase 13 Human genes 0.000 description 1
- 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 102100023483 Mitogen-activated protein kinase 15 Human genes 0.000 description 1
- 102100024189 Mitogen-activated protein kinase 4 Human genes 0.000 description 1
- 102100037801 Mitogen-activated protein kinase 6 Human genes 0.000 description 1
- 102100037805 Mitogen-activated protein kinase 7 Human genes 0.000 description 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 1
- 102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 description 1
- 102100038243 Mitogen-activated protein kinase kinase kinase 10 Human genes 0.000 description 1
- 102100025207 Mitogen-activated protein kinase kinase kinase 11 Human genes 0.000 description 1
- 102100025180 Mitogen-activated protein kinase kinase kinase 12 Human genes 0.000 description 1
- 102100025184 Mitogen-activated protein kinase kinase kinase 13 Human genes 0.000 description 1
- 102100025211 Mitogen-activated protein kinase kinase kinase 14 Human genes 0.000 description 1
- 102100025216 Mitogen-activated protein kinase kinase kinase 15 Human genes 0.000 description 1
- 102100025217 Mitogen-activated protein kinase kinase kinase 19 Human genes 0.000 description 1
- 102100033058 Mitogen-activated protein kinase kinase kinase 2 Human genes 0.000 description 1
- 102100033116 Mitogen-activated protein kinase kinase kinase 20 Human genes 0.000 description 1
- 102100033054 Mitogen-activated protein kinase kinase kinase 21 Human genes 0.000 description 1
- 102100033059 Mitogen-activated protein kinase kinase kinase 3 Human genes 0.000 description 1
- 102100033060 Mitogen-activated protein kinase kinase kinase 4 Human genes 0.000 description 1
- 102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 description 1
- 102100026889 Mitogen-activated protein kinase kinase kinase 6 Human genes 0.000 description 1
- 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 1
- 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 1
- 102100026909 Mitogen-activated protein kinase kinase kinase 9 Human genes 0.000 description 1
- 102100028199 Mitogen-activated protein kinase kinase kinase kinase 1 Human genes 0.000 description 1
- 102100028192 Mitogen-activated protein kinase kinase kinase kinase 2 Human genes 0.000 description 1
- 102100028193 Mitogen-activated protein kinase kinase kinase kinase 3 Human genes 0.000 description 1
- 102100028194 Mitogen-activated protein kinase kinase kinase kinase 4 Human genes 0.000 description 1
- 102100028195 Mitogen-activated protein kinase kinase kinase kinase 5 Human genes 0.000 description 1
- 102100030144 Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Human genes 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 101100096028 Mus musculus Smok1 gene Proteins 0.000 description 1
- 101100042839 Mus musculus Smok2a gene Proteins 0.000 description 1
- 101100042840 Mus musculus Smok2b gene Proteins 0.000 description 1
- 101100042841 Mus musculus Smok3a gene Proteins 0.000 description 1
- 101100042842 Mus musculus Smok3b gene Proteins 0.000 description 1
- 101100042844 Mus musculus Smoktcr gene Proteins 0.000 description 1
- 101100042845 Mus musculus Stk-ps2 gene Proteins 0.000 description 1
- 101100262126 Mus musculus Tssk5 gene Proteins 0.000 description 1
- VQPRNSWQIAHPMS-HNNXBMFYSA-N N(6)-dansyl-L-lysine Chemical group C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)NCCCC[C@H](N)C(O)=O VQPRNSWQIAHPMS-HNNXBMFYSA-N 0.000 description 1
- JOOXLOJCABQBSG-UHFFFAOYSA-N N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide Chemical compound N1=C(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)(C)C)C(C)=CN=C1NC(C=C1)=CC=C1OCCN1CCCC1 JOOXLOJCABQBSG-UHFFFAOYSA-N 0.000 description 1
- 102000042874 NEK Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091082296 NEK Ser/Thr protein kinase family Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241001443978 Oplophorus Species 0.000 description 1
- 241000522587 Oplophorus gracilirostris Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000041706 PDK/BCKDK protein kinase family Human genes 0.000 description 1
- 108091075311 PDK/BCKDK protein kinase family Proteins 0.000 description 1
- 102000042685 PI3/PI4-kinase family Human genes 0.000 description 1
- 108091081974 PI3/PI4-kinase family Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 1
- 102100036052 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human genes 0.000 description 1
- 101710115400 Phosphatidylinositol 4-kinase LSB6 Proteins 0.000 description 1
- 101710140706 Phosphatidylinositol 4-kinase PIK1 Proteins 0.000 description 1
- 101710185028 Phosphatidylinositol 4-kinase stt4 Proteins 0.000 description 1
- 102100026481 Phosphoinositide 3-kinase regulatory subunit 4 Human genes 0.000 description 1
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 1
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108010015499 Protein Kinase C-theta Proteins 0.000 description 1
- 108010003506 Protein Kinase D2 Proteins 0.000 description 1
- 102100028655 Protein O-mannose kinase Human genes 0.000 description 1
- 101710086532 Protein O-mannose kinase Proteins 0.000 description 1
- 102100024923 Protein kinase C beta type Human genes 0.000 description 1
- 102100037340 Protein kinase C delta type Human genes 0.000 description 1
- 102100037339 Protein kinase C epsilon type Human genes 0.000 description 1
- 102100021556 Protein kinase C eta type Human genes 0.000 description 1
- 102100037314 Protein kinase C gamma type Human genes 0.000 description 1
- 102100021557 Protein kinase C iota type Human genes 0.000 description 1
- 102100021566 Protein kinase C theta type Human genes 0.000 description 1
- 102100021538 Protein kinase C zeta type Human genes 0.000 description 1
- 108010091528 Proto-Oncogene Proteins B-raf Proteins 0.000 description 1
- 102000018471 Proto-Oncogene Proteins B-raf Human genes 0.000 description 1
- 102100037266 Putative 3-phosphoinositide-dependent protein kinase 2 Human genes 0.000 description 1
- 102100029403 Putative serine/threonine-protein kinase PRKY Human genes 0.000 description 1
- 101710141955 RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
- 102000042869 RIO-type Ser/Thr kinase family Human genes 0.000 description 1
- 108091082300 RIO-type Ser/Thr kinase family Proteins 0.000 description 1
- KAEGGIFPLJZUOZ-UHFFFAOYSA-N Renilla luciferin Chemical compound C1=CC(O)=CC=C1C(N1)=CN2C(=O)C(CC=3C=CC=CC=3)=NC2=C1CC1=CC=CC=C1 KAEGGIFPLJZUOZ-UHFFFAOYSA-N 0.000 description 1
- 108020003564 Retroelements Proteins 0.000 description 1
- 102100023742 Rhodopsin kinase GRK1 Human genes 0.000 description 1
- 102100033090 Rhodopsin kinase GRK7 Human genes 0.000 description 1
- 102100033536 Ribosomal protein S6 kinase alpha-1 Human genes 0.000 description 1
- 102100033534 Ribosomal protein S6 kinase alpha-2 Human genes 0.000 description 1
- 102100033643 Ribosomal protein S6 kinase alpha-3 Human genes 0.000 description 1
- 102100033644 Ribosomal protein S6 kinase alpha-4 Human genes 0.000 description 1
- 102100033645 Ribosomal protein S6 kinase alpha-5 Human genes 0.000 description 1
- 102100024897 Ribosomal protein S6 kinase alpha-6 Human genes 0.000 description 1
- 102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 description 1
- 102100024917 Ribosomal protein S6 kinase beta-2 Human genes 0.000 description 1
- 102100024913 Ribosomal protein S6 kinase delta-1 Human genes 0.000 description 1
- 102100030864 Ribosomal protein S6 kinase-like 1 Human genes 0.000 description 1
- 102100024914 Ribosomal protein S6 kinase-related protein Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 102000042891 STE Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091082314 STE Ser/Thr protein kinase family Proteins 0.000 description 1
- 102100035929 STE20-related kinase adapter protein beta Human genes 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100029854 Serine/threonine kinase-like domain-containing protein STKLD1 Human genes 0.000 description 1
- 102100028900 Serine/threonine-protein kinase 10 Human genes 0.000 description 1
- 102100037955 Serine/threonine-protein kinase 17A Human genes 0.000 description 1
- 102100037959 Serine/threonine-protein kinase 17B Human genes 0.000 description 1
- 102100028032 Serine/threonine-protein kinase 32A Human genes 0.000 description 1
- 102100028030 Serine/threonine-protein kinase 32B Human genes 0.000 description 1
- 102100027903 Serine/threonine-protein kinase 32C Human genes 0.000 description 1
- 102100027898 Serine/threonine-protein kinase 38-like Human genes 0.000 description 1
- 102100037310 Serine/threonine-protein kinase D1 Human genes 0.000 description 1
- 102100037312 Serine/threonine-protein kinase D2 Human genes 0.000 description 1
- 102100037311 Serine/threonine-protein kinase D3 Human genes 0.000 description 1
- 102100028475 Serine/threonine-protein kinase H2 Human genes 0.000 description 1
- 102100028774 Serine/threonine-protein kinase Nek10 Human genes 0.000 description 1
- 102100024149 Serine/threonine-protein kinase PDIK1L Human genes 0.000 description 1
- 102100028868 Serine/threonine-protein kinase PRP4 homolog Human genes 0.000 description 1
- 102100037670 Serine/threonine-protein kinase TNNI3K Human genes 0.000 description 1
- 101710083997 Serine/threonine-protein kinase greatwall Proteins 0.000 description 1
- 102100029332 Serine/threonine-protein kinase haspin Human genes 0.000 description 1
- 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 description 1
- 102100033456 TGF-beta receptor type-1 Human genes 0.000 description 1
- 102100033455 TGF-beta receptor type-2 Human genes 0.000 description 1
- 102000042893 TKL Ser/Thr protein kinase family Human genes 0.000 description 1
- 108091082317 TKL Ser/Thr protein kinase family Proteins 0.000 description 1
- 102100029350 Testis-specific serine/threonine-protein kinase 1 Human genes 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010011702 Transforming Growth Factor-beta Type I Receptor Proteins 0.000 description 1
- 108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 1
- 102100026387 Tribbles homolog 1 Human genes 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 1
- 102000042897 Tyr protein kinase family Human genes 0.000 description 1
- 108091082320 Tyr protein kinase family Proteins 0.000 description 1
- 102100021788 Tyrosine-protein kinase Yes Human genes 0.000 description 1
- 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 description 1
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 1
- 102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 229960001686 afatinib Drugs 0.000 description 1
- ULXXDDBFHOBEHA-CWDCEQMOSA-N afatinib Chemical compound N1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC1=CC=C(F)C(Cl)=C1 ULXXDDBFHOBEHA-CWDCEQMOSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 229960001611 alectinib Drugs 0.000 description 1
- KDGFLJKFZUIJMX-UHFFFAOYSA-N alectinib Chemical compound CCC1=CC=2C(=O)C(C3=CC=C(C=C3N3)C#N)=C3C(C)(C)C=2C=C1N(CC1)CCC1N1CCOCC1 KDGFLJKFZUIJMX-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000012440 amplified luminescent proximity homogeneous assay Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229950009576 avapritinib Drugs 0.000 description 1
- 229960003005 axitinib Drugs 0.000 description 1
- RITAVMQDGBJQJZ-FMIVXFBMSA-N axitinib Chemical compound CNC(=O)C1=CC=CC=C1SC1=CC=C(C(\C=C\C=2N=CC=CC=2)=NN2)C2=C1 RITAVMQDGBJQJZ-FMIVXFBMSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- SJCPQBRQOOJBFM-UHFFFAOYSA-N benzo[a]phenalen-1-one Chemical class C1=CC=C2C(C(=O)C=C3)=C4C3=CC=CC4=CC2=C1 SJCPQBRQOOJBFM-UHFFFAOYSA-N 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 229950003054 binimetinib Drugs 0.000 description 1
- ACWZRVQXLIRSDF-UHFFFAOYSA-N binimetinib Chemical compound OCCONC(=O)C=1C=C2N(C)C=NC2=C(F)C=1NC1=CC=C(Br)C=C1F ACWZRVQXLIRSDF-UHFFFAOYSA-N 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 229950004272 brigatinib Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102100033065 cAMP-dependent protein kinase catalytic subunit beta Human genes 0.000 description 1
- 102100033064 cAMP-dependent protein kinase catalytic subunit gamma Human genes 0.000 description 1
- 102100022421 cGMP-dependent protein kinase 2 Human genes 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 229960001602 ceritinib Drugs 0.000 description 1
- WRXDGGCKOUEOPW-UHFFFAOYSA-N ceritinib Chemical compound CC=1C=C(NC=2N=C(NC=3C(=CC=CC=3)NS(=O)(=O)C(C)C)C(Cl)=CN=2)C(OC(C)C)=CC=1C1CCNCC1 WRXDGGCKOUEOPW-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002271 cobimetinib Drugs 0.000 description 1
- RESIMIUSNACMNW-BXRWSSRYSA-N cobimetinib fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1C(O)([C@H]2NCCCC2)CN1C(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F.C1C(O)([C@H]2NCCCC2)CN1C(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1F RESIMIUSNACMNW-BXRWSSRYSA-N 0.000 description 1
- LSSJELUXTIYYDZ-UHFFFAOYSA-N coelenterazine e Chemical compound C1=CC(O)=CC=C1CC(C(N1C=2CCC3=CC(O)=CC=C3C=2N2)=O)=NC1=C2CC1=CC=CC=C1 LSSJELUXTIYYDZ-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960005061 crizotinib Drugs 0.000 description 1
- KTEIFNKAUNYNJU-GFCCVEGCSA-N crizotinib Chemical compound O([C@H](C)C=1C(=C(F)C=CC=1Cl)Cl)C(C(=NC=1)N)=CC=1C(=C1)C=NN1C1CCNCC1 KTEIFNKAUNYNJU-GFCCVEGCSA-N 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229960002465 dabrafenib Drugs 0.000 description 1
- BFSMGDJOXZAERB-UHFFFAOYSA-N dabrafenib Chemical compound S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 BFSMGDJOXZAERB-UHFFFAOYSA-N 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000005292 diamagnetic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 102100034175 eIF-2-alpha kinase GCN2 Human genes 0.000 description 1
- 229950001969 encorafenib Drugs 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229950000521 entrectinib Drugs 0.000 description 1
- 239000005447 environmental material Substances 0.000 description 1
- 229950004444 erdafitinib Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950003487 fedratinib Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229960005191 ferric oxide Drugs 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- RJOJUSXNYCILHH-UHFFFAOYSA-N gadolinium(3+) Chemical compound [Gd+3] RJOJUSXNYCILHH-UHFFFAOYSA-N 0.000 description 1
- CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(III) oxide Inorganic materials [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229950006304 gilteritinib Drugs 0.000 description 1
- GYQYAJJFPNQOOW-UHFFFAOYSA-N gilteritinib Chemical compound N1=C(NC2CCOCC2)C(CC)=NC(C(N)=O)=C1NC(C=C1OC)=CC=C1N(CC1)CCC1N1CCN(C)CC1 GYQYAJJFPNQOOW-UHFFFAOYSA-N 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- 229950003970 larotrectinib Drugs 0.000 description 1
- 229960003784 lenvatinib Drugs 0.000 description 1
- WOSKHXYHFSIKNG-UHFFFAOYSA-N lenvatinib Chemical compound C=12C=C(C(N)=O)C(OC)=CC2=NC=CC=1OC(C=C1Cl)=CC=C1NC(=O)NC1CC1 WOSKHXYHFSIKNG-UHFFFAOYSA-N 0.000 description 1
- CMJCXYNUCSMDBY-ZDUSSCGKSA-N lgx818 Chemical compound COC(=O)N[C@@H](C)CNC1=NC=CC(C=2C(=NN(C=2)C(C)C)C=2C(=C(NS(C)(=O)=O)C=C(Cl)C=2)F)=N1 CMJCXYNUCSMDBY-ZDUSSCGKSA-N 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229950001290 lorlatinib Drugs 0.000 description 1
- IIXWYSCJSQVBQM-LLVKDONJSA-N lorlatinib Chemical compound N=1N(C)C(C#N)=C2C=1CN(C)C(=O)C1=CC=C(F)C=C1[C@@H](C)OC1=CC2=CN=C1N IIXWYSCJSQVBQM-LLVKDONJSA-N 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 229950010895 midostaurin Drugs 0.000 description 1
- BMGQWWVMWDBQGC-IIFHNQTCSA-N midostaurin Chemical compound CN([C@H]1[C@H]([C@]2(C)O[C@@H](N3C4=CC=CC=C4C4=C5C(=O)NCC5=C5C6=CC=CC=C6N2C5=C43)C1)OC)C(=O)C1=CC=CC=C1 BMGQWWVMWDBQGC-IIFHNQTCSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- OLAHOMJCDNXHFI-UHFFFAOYSA-N n'-(3,5-dimethoxyphenyl)-n'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-n-propan-2-ylethane-1,2-diamine Chemical compound COC1=CC(OC)=CC(N(CCNC(C)C)C=2C=C3N=C(C=NC3=CC=2)C2=CN(C)N=C2)=C1 OLAHOMJCDNXHFI-UHFFFAOYSA-N 0.000 description 1
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- HAYYBYPASCDWEQ-UHFFFAOYSA-N n-[5-[(3,5-difluorophenyl)methyl]-1h-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide Chemical compound C1CN(C)CCN1C(C=C1NC2CCOCC2)=CC=C1C(=O)NC(C1=C2)=NNC1=CC=C2CC1=CC(F)=CC(F)=C1 HAYYBYPASCDWEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000010309 neoplastic transformation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960004378 nintedanib Drugs 0.000 description 1
- XZXHXSATPCNXJR-ZIADKAODSA-N nintedanib Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CN1CCN(C)CC1 XZXHXSATPCNXJR-ZIADKAODSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 230000004650 oncogenic pathway Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- UCDPMNSCCRBWIC-UHFFFAOYSA-N orthosulfamuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)NC=2C(=CC=CC=2)C(=O)N(C)C)=N1 UCDPMNSCCRBWIC-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229950001457 pexidartinib Drugs 0.000 description 1
- JGWRKYUXBBNENE-UHFFFAOYSA-N pexidartinib Chemical compound C1=NC(C(F)(F)F)=CC=C1CNC(N=C1)=CC=C1CC1=CNC2=NC=C(Cl)C=C12 JGWRKYUXBBNENE-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 108060006184 phycobiliprotein Proteins 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229960001131 ponatinib Drugs 0.000 description 1
- PHXJVRSECIGDHY-UHFFFAOYSA-N ponatinib Chemical compound C1CN(C)CCN1CC(C(=C1)C(F)(F)F)=CC=C1NC(=O)C1=CC=C(C)C(C#CC=2N3N=CC=CC3=NC=2)=C1 PHXJVRSECIGDHY-UHFFFAOYSA-N 0.000 description 1
- 230000016833 positive regulation of signal transduction Effects 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 108010062154 protein kinase C gamma Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960004836 regorafenib Drugs 0.000 description 1
- FNHKPVJBJVTLMP-UHFFFAOYSA-N regorafenib Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=C(F)C(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 FNHKPVJBJVTLMP-UHFFFAOYSA-N 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 102200006538 rs121913530 Human genes 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229960000215 ruxolitinib Drugs 0.000 description 1
- HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 description 1
- 229950010746 selumetinib Drugs 0.000 description 1
- CYOHGALHFOKKQC-UHFFFAOYSA-N selumetinib Chemical compound OCCONC(=O)C=1C=C2N(C)C=NC2=C(F)C=1NC1=CC=C(Br)C=C1Cl CYOHGALHFOKKQC-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960003787 sorafenib Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 229960001796 sunitinib Drugs 0.000 description 1
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 229960004066 trametinib Drugs 0.000 description 1
- LIRYPHYGHXZJBZ-UHFFFAOYSA-N trametinib Chemical compound CC(=O)NC1=CC=CC(N2C(N(C3CC3)C(=O)C3=C(NC=4C(=CC(I)=CC=4)F)N(C)C(=O)C(C)=C32)=O)=C1 LIRYPHYGHXZJBZ-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 108010072106 tumstatin (74-98) Proteins 0.000 description 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960000241 vandetanib Drugs 0.000 description 1
- UHTHHESEBZOYNR-UHFFFAOYSA-N vandetanib Chemical compound COC1=CC(C(/N=CN2)=N/C=3C(=CC(Br)=CC=3)F)=C2C=C1OCC1CCN(C)CC1 UHTHHESEBZOYNR-UHFFFAOYSA-N 0.000 description 1
- 229960003862 vemurafenib Drugs 0.000 description 1
- GPXBXXGIAQBQNI-UHFFFAOYSA-N vemurafenib Chemical compound CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C=2C3=CC(=CN=C3NC=2)C=2C=CC(Cl)=CC=2)=C1F GPXBXXGIAQBQNI-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
Definitions
- kinases by kinase binding agents.
- the engagement of kinases by functional kinase binding agents is enhanced by the co-expression of the kinases with an active variant of KRAS.
- the human genome contains about 560 protein kinase genes, and they constitute about 2% of all human genes (Manning et al. (2002) Science 298 (5600): 1912-1934.; herein incorporated by reference in its entirety). Up to 30% of all human proteins may be modified by kinase activity, and kinases are known to regulate the majority of cellular pathways, especially those involved in signal transduction.
- the chemical activity of a kinase involves transferring a phosphate group from a nucleoside triphosphate (usually ATP) and covalently attaching it to specific amino acids with a free hydroxyl group.
- kinases act on both serine and threonine (serine/threonine kinases), others act on tyrosine (tyrosine kinases), and a number act on all three (dhanasekaran & Premkumar (September 1998). Oncogene. 17 (11 Reviews): 1447-55.; herein incorporated by reference in its entirety). Aberrant kinase signaling is associated with many diseases and conditions.
- the KRAS gene encodes the KRAS protein, which is part of the RAS/MAPK pathway. KRAS relays signals from outside the cell to the cell's nucleus that instruct the cell to grow, divide, mature, and/or differentiate. KRAS is a GTPase that acts as a molecular switch, turning on and off by the conversion of GTP to GDP.
- the KRAS gene is an oncogene and, when mutated, can cause normal cells to become cancerous.
- KRAS-activating mutations are the most frequent oncogenic alterations in human cancer.
- KRAS G12C One common KRAS- activating mutation that drives neoplastic transformation in cells is KRAS G12C . KRAS-activating mutations such as KRAS G12C fix the KRAS protein in its active GTP-bound form by interfering with the GTP to GDP cycling process.
- kinases by kinase binding agents.
- the engagement of kinases by functional kinase binding agents is enhanced by the co-expression of the kinases with an active variant of KRAS.
- kinase binding agent is a functional kinase binding agent and comprises a kinase binding moiety and a functional element.
- the kinase binding agent consists of a kinase binding moiety.
- methods further comprise (c) detecting or quantifying the functional element.
- step (a) comprises contacting a sample comprising the kinase with the active KRAS variant. In some embodiments, step (a) comprises expressing the kinase and the active KRAS variant within the sample.
- the active KRAS variant is an active variant of the KRAS4A isoform (e.g., KRAS4A G12C , KRAS4A G12D , KRAS4A G12V , etc.).
- the active KRAS variant is an active variant of the KRAS4B isoform (e.g., KRAS4B G12C , KRAS4B G12D , KRAS4B G12V , etc.).
- the active KRAS variant is a KRAS G12C variant (e.g., KRAS4B G12C , KRAS4B G12C , etc.).
- the functional element is a detectable element, an affinity element, a capture element, or a solid support.
- the functional element is a detectable element selected from a fluorophore, chromophore, radionuclide, electron opaque molecule, an MRI contrast agent, SPECT contrast agent, and mass tag.
- the detectable element, or the signal produced thereby is detected or quantified by fluorescence, mass spectrometry, optical imaging, magnetic resonance imaging (MRI), or energy transfer.
- the functional element is a solid support selected from a sedimental particle, a membrane, glass, a tube, a well, a self-assembled monolayer, a surface plasmon resonance chip, and a solid support with an electron conducting surface.
- the sedimental particle is a magnetic particle.
- the broad-spectrum kinase binding agent is of the formula: and is attached to the detectable functional element.
- the sample is selected from a cell, cell lysate, body fluid, tissue, biological sample, in vitro sample, and environmental sample.
- the kinase is expressed as a fusion with a bioluminescent reporter.
- the bioluminescent reporter is a luciferase with at least 70% sequence identity with SEQ ID NO: 4.
- the emission spectrum of the bioluminescent reporter and the excitation spectrum of the functional element overlap.
- methods further comprise contacting the sample with a substrate for the bioluminescent reporter.
- the substrate is coelenterazine, a coelenterazine derivative, or furimazine.
- a target kinase e.g., a plurality of target kinases
- an active variant of KRAS and
- a kinase binding agent comprising a kinase binding moiety.
- the kinase binding agent is a functionalized kinase binding agent and comprises a kinase binding moiety and a functional element.
- the kinase binding agent consists of a kinase binding moiety.
- the system comprises a cell, cell lysate, tissue, or cell-free system.
- the kinase and the active KRAS variant are expressed within the system.
- the active KRAS variant is an active variant of the KRAS4A isoform (e.g., KRAS4A G12C , KRAS4A g12D , KRAS4A g12V , etc.) ⁇
- the active KRAS variant is an active variant of the KRAS4B isoform (e.g., KRAS4B G12C ,
- the active KRAS variant is a KRAS g12C variant (e.g., KRAS4B G12C , KRAS4B G12C , etc.).
- the functional element is a detectable element, an affinity element, a capture element, or a solid support.
- the functional element is a detectable element selected from a fluorophore, chromophore, radionuclide, electron opaque molecule, an MRI contrast agent, SPECT contrast agent, and mass tag.
- the detectable element, or the signal produced thereby is detectable or quantifiable by fluorescence, mass spectrometry, optical imaging, magnetic resonance imaging (MRI), or energy transfer.
- the functional element is a solid support selected from a sedimental particle, a membrane, glass, a tube, a well, a self-assembled monolayer, a surface plasmon resonance chip, and a solid support with an electron conducting surface.
- the sedimental particle is a magnetic particle.
- the kinase binding agent is general kinase inhibitor or a specific kinase inhibitor (e.g., a drug molecule that binds to and inhibits one or more kinases).
- the broad-spectrum kinase binding agent is of the formula:
- the system comprises a sample is selected from a cell, cell lysate, body fluid, tissue, biological sample, in vitro sample, and environmental sample.
- the kinase is present as a fusion with a bioluminescent reporter.
- the bioluminescent reporter is a luciferase with at least 70% sequence identity with SEQ ID NO: 4.
- the emission spectrum of the bioluminescent reporter and the excitation spectrum of the functional element overlap.
- systems further comprise a substrate for the bioluminescent reporter.
- the substrate is coelenterazine, a coelenterazine derivative, or furimazine.
- the systems and methods provided herein utilize functional kinase binding agents which comprise a first moiety capable of bind to a kinase protein (e.g., a broad spectrum of kinase proteins) and second functional element (e.g., detectable element, capture element, affinity element, solid support, etc.), such as those described in U.S. Pub No. 2020/000771; incorporated by reference in its entirety.
- a kinase protein e.g., a broad spectrum of kinase proteins
- second functional element e.g., detectable element, capture element, affinity element, solid support, etc.
- a detectable element comprises a fluorophore, chromophore, radionuclide, electron opaque molecule, an MRI contrast agent, SPECT contrast agent, or mass tag.
- a solid surface is selected from a sedimental particle, a membrane, glass, a tube, a well, a self- assembled monolayer, a surface plasmon resonance chip, or a solid support with an electron conducting surface.
- the sedimental particle is a magnetic particle.
- a broad-spectrum kinase binding agent is attached to the detectable element directly.
- a broad-spectrum kinase binding agent is attached to the detectable element via a linker.
- the linker comprises - [(CH 2 ) 2 0]n-, wherein n is 1-20 (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 20, or ranges therebetween).
- the linker is attached to the broad- spectrum kinase binding agent and/or the detectable element by an amide bond.
- X is a functional element (e.g., detectable element, capture element, affinity element, solid surface, etc.). In some embodiments, X is a fluorophore. In some embodiments, provided herein is a functional kinase binding agent comprising a structure of:
- a functional kinase binding agent comprising a structure of: wherein X is a functional element (e.g., detectable element, capture element, affinity element solid surface, etc.). In some embodiments, X is a fluorophore. In some embodiments, provided herein is a functional kinase binding agent comprising a structure of:
- a functional kinase binding agent comprising a structure of: wherein X is a functional element (e.g., detectable element, capture element, affinity element, solid surface, etc.). In some embodiments, X is a fluorophore. In some embodiments, provided herein is a functional kinase binding agent comprising a structure of:
- a functional kinase binding agent comprises a non-natural abundance of one or more stable heavy isotopes.
- detecting or quantifying kinases in a sample comprising contacting the sample with a functional kinase binding agent and detecting or quantifying the detectable element or a signal produced thereby.
- the detectable element, or a signal produced thereby is detected or quantified by fluorescence, mass spectrometry, optical imaging, magnetic resonance imaging (MRI), or energy transfer (e g., FRET, BRET, ALPHA).
- methods of isolating kinases from a sample comprising contacting the sample with a functional kinase binding agent and separating the complex of the functional kinase binding agent and a bound kinase from the unbound portion of the sample based on the functionality of the functional element (e.g., capture element, affinity element, solid surface, etc.).
- methods comprise isolating the kinases from a sample by a method described herein and analyzing the isolated kinases by mass spectrometry.
- provided herein are methods of monitoring interactions between kinases and unmodified biomolecules comprising contacting the sample with a functional kinase binding agent herein.
- methods herein are performed using a sample selected from a cell, cell lysate, body fluid, tissue, biological sample, in vitro sample, and environmental sample.
- FIG. 1A-F Impact of KRAS4B G12C on kinase engagement.
- A Molecular structures of pan-kinase inhibitor CC1 and functional kinase binding agent K10.
- B Affinity of K10 tracer vs. CC1 standard for BRAF.
- C Affinity of K10 tracer vs. CC1 standard for JAK2.
- D Affinity of K10 tracer vs. CC1 standard for MAPK1.
- E Affinity of K10 tracer vs. CC1 standard for BTK.
- F Affinity of K10 tracer vs. CC1 standard for MAPK3.
- the term “and/or” includes any and all combinations of listed items, including any of the listed items individually.
- “A, B, and/or C” encompasses A, B, C, AB, AC, BC, and ABC, each of which is to be considered separately described by the statement “A, B, and/or C.”
- the term “comprise” and linguistic variations thereof denote the presence of recited feature(s), element(s), method step(s), etc., without the exclusion of the presence of additional feature(s), element(s), method step(s), etc.
- the term “consisting of’ and linguistic variations thereof denotes the presence of recited feature(s), element(s), method step(s), etc., and excludes any unrecited feature(s), element(s), method step(s), etc., except for ordinarily-associated impurities.
- tracer refers to a compound of interest or an agent that binds to an analyte of interest (e.g., protein of interest (e.g., kinase), etc.) and displays a moiety with a quantifiable or detectable property (e.g., detected or quantified any suitable biochemical or biophysical technique (e.g., optically, magnetically, electrically, by resonance imaging, by mass, by radiation, etc.)).
- analyte of interest e.g., protein of interest (e.g., kinase), etc.
- a quantifiable or detectable property e.g., detected or quantified any suitable biochemical or biophysical technique (e.g., optically, magnetically, electrically, by resonance imaging, by mass, by radiation, etc.)).
- Tracers may comprise a compound of interest or an agent that binds to an analyte of interest linked (e.g., directly or via a suitable linker) to a fluorophore, radionuclide, mass tag, contrast agent for magnetic resonance imaging (MRI), planar scintigraphy (PS), positron emission tomography (PET), single photon emission computed tomography (SPECT), and computed tomography (CT) (e.g., a metal ion chelator with bound metal ion, isotope, or radionuclide), etc.
- MRI magnetic resonance imaging
- PS planar scintigraphy
- PET positron emission tomography
- SPECT single photon emission computed tomography
- CT computed tomography
- sample is used in its broadest sense. In one sense, it is meant to include a specimen or culture obtained from any source as well as biological and environmental samples. Biological samples may be obtained from animals (including humans) and encompass fluids, solids, tissues, and gases. Biological samples include blood products such as plasma, serum, and the like. Sample may also refer to cell lysates or purified forms of the enzymes, peptides, and/or polypeptides described herein. Cell lysates may include cells that have been lysed with a lysing agent or lysates such as rabbit reticulocyte or wheat germ lysates. Sample may also include cell-free expression systems. Environmental samples include environmental material such as surface matter, soil, water, crystals, and industrial samples. Such examples are not however to be construed as limiting the sample types applicable to the present invention.
- linearly connected atoms refers to the backbone atoms of a chain or polymer, excluding pendant, side chain, or H atoms that do not form the main chain or backbone.
- detectable element refers to a detectable, reactive, affinity, or otherwise bioactive agent or moiety that is attached (e.g., directly or via a suitable linker) to a compound described herein derivatives or analogs thereof, etc.).
- Other additional detectable elements that may find use in embodiments described herein comprise “localization elements”, “detection elements”, etc.
- capture element refers to a molecular entity that forms a covalent interaction with a corresponding “capture agent.”
- affinity element refers to a molecular entity that forms a stable noncovalent interaction with a corresponding “affinity agent.”
- solid support is used in reference to any solid or stationary material to which reagents such as substrates, mutant proteins, drug-like molecules, and other test components are or may be attached.
- reagents such as substrates, mutant proteins, drug-like molecules, and other test components are or may be attached.
- solid supports include microscope slides, wells of microtiter plates, coverslips, beads, particles, resin, cell culture flasks, as well as many other suitable items.
- the beads, particles, or resin can be magnetic or paramagnetic.
- the indication represents a point of attachment of one moiety to another moiety (e.g., kinase binding agent to a functional element).
- Coelenterazine refers to naturally-occurring (“native”) coelenterazine.
- coelenterazine analog or “coelenterazine derivative” refers to synthetic (e.g., derivative or variant) and natural analogs thereof, including furimazine, coelenterazine-n, coelenterazine-f, coelenterazine-h, coelenterazine- hcp, coelenterazine-cp, coelenterazine-c, coelenterazine-e, coelenterazine-fcp, bis- deoxy coelenterazine (“coelenterazine-hh”), coelenterazine-i, coelenterazine-icp, coelenterazine-v, and 2-methyl coelenterazine, in addition to those disclosed in WO 2003/040100; U.S.
- coelenterazine analogs include pro-substrates such as, for example, those described in U.S. Application Ser. No. 12/056,073; U.S. Pub. No. 2012/0707849; U.S. Pub. No. 2014/0099654; herein incorporated by reference in their entireties.
- the term “peptide” typically refers to short amino acid polymers (e.g., chains having fewer than 25 amino acids), whereas the term “polypeptide” typically refers to longer amino acid polymers (e.g., chains having more than 25 amino acids).
- “Variant” is used herein to describe a peptide or polypeptide that differs in amino acid sequence by the insertion, deletion, or conservative substitution of amino acids, but retain at least one biological activity.
- “SNP” refers to a variant that is a single nucleotide polymorphism.
- Representative examples of “biological activity” include the ability to be bound by a specific antibody or to promote an immune response.
- Variant is also used herein to describe a protein with an amino acid sequence that is substantially identical to a referenced protein with an amino acid sequence that retains at least one biological activity.
- a conservative substitution of an amino acid is recognized in the art as typically involving a minor change. These minor changes can be identified, in part, by considering the hydropathic index of amino acids, as understood in the art.
- the hydropathic index of an amino acid is based on a consideration of its hydrophobicity and charge. It is known in the art that amino acids of similar hydropathic indexes can be substituted and still retain protein function. In one aspect, amino acids having hydropathic indexes of ⁇ 2 are substituted.
- the hydrophilicity of amino acids can also be used to reveal substitutions that would result in proteins retaining biological function.
- hydrophilicity of amino acids in the context of a peptide permits calculation of the greatest local average hydrophilicity of that peptide, a useful measure that has been reported to correlate well with antigenicity and immunogenicity.
- Substitution of amino acids having similar hydrophilicity values can result in peptides retaining biological activity, for example immunogenicity, as is understood in the art. Substitutions may be performed with amino acids having hydrophilicity values within ⁇ 2 of each other. Both the hydrophobicity index and the hydrophilicity value of amino acids are influenced by the particular side chain of that amino acid. Consistent with that observation, amino acid substitutions that are compatible with biological function are understood to depend on the relative similarity of the amino acids, and particularly the side chains of those amino acids, as revealed by the hydrophobicity, hydrophilicity, charge, size, and other properties.
- kinases by kinase binding agents.
- the engagement of kinases by functional kinase binding agents is enhanced by the co-expression of the kinases with an active variant of KRAS.
- an active variant of KRAS e.g., KRAS4A variants, KRAS4B variants, variants of KRAS G12C , variants of KRAS G12D , variants of KRAS G12V , etc.
- KRAS4A variants, KRAS4B variants, variants of KRAS G12C , variants of KRAS G12D , variants of KRAS G12V , etc. is provided herein are systems and methods for the engagement of kinases in which an active variant of KRAS (e.g., KRAS4A variants, KRAS4B variants, variants of KRAS G12C , variants of KRAS G12D , variants of KRAS G12V , etc.) is provided along with a functional kinase binding agent.
- the presence of the active KRAS protein activates the RAS/MAPK pathway, and other kinase rich pathways associated therewith, thereby enhancing target engagement by functional kinase binding agent; however, embodiments herein are not limited to this mechanism of action and an understanding of the mechanism underlying the systems and methods herein is not necessary to practice the invention.
- the enhanced target engagement that occurs in the presence of an active variant of KRAS e.g., KRAS4A variants, KRAS4B variants, variants of KRAS G12C , variants of KRAS G12D , variants of KRAS G12V , etc.
- KRAS4A variants, KRAS4B variants, variants of KRAS G12C , variants of KRAS G12D , variants of KRAS G12V , etc. provides systems and methods with enhanced detection, quantification, purification, isolation, etc. of kinases.
- any embodiments herein may also find use in the detection/isolation of other proteins, for example, if the activity and/or expression of those proteins is enhanced by the presence/co-expression of the active KRAS (e.g., KRAS4A G12C , KRAS4A g12D , KRAS4A G12V , KRAS4B G12C , KRAS4B G12D , KRAS4B G12V , etc.).
- KRAS4A G12C , KRAS4A g12D , KRAS4A G12V , KRAS4B G12C , KRAS4B G12D , KRAS4B G12V , etc. the active KRAS
- proteins that are activated/expressed in KRAS pathways are more readily detected/isolated in the presence of an active variant of KRAS.
- active KRAS variants e.g., kinases, non kinases, or pathways associated therewith.
- the active KRAS variant is an active variant of the KRAS4A isoform (e.g., KRAS4A G12C , KRAS4A G12D , KRAS4A G12V , etc.).
- the active KRAS variant is an active variant of the KRAS4B isoform (e.g., KRAS4B G12C , KRAS4B G12D , KRAS4B G12V , etc ).
- an active variant of KRAS4A (SEQ ID NO: 2).
- active variants of KRAS4A are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 2.
- an active KRAS4A variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 2.
- an active KRAS4A variant comprises a substitution at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4A (SEQ ID NO: 2) are provided and/or expressed.
- sequences encoding active variants of KRAS4A are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4A sequence SEQ ID NO:
- sequences comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 1 are provided.
- a KRAS4A variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 1.
- a KRAS4A variant nucleotide sequence comprises a substitution at one or more of positions 34, 35 or 36 of SEQ ID NO: 1.
- methods of enhanced target engagement comprising providing a KRAS4A variant nucleotide sequence (e.g., a variant of SEQ ID NO: 1) that encodes and active KRAS4A variant.
- systems for enhanced target engagement comprising an active variant of KRAS4A G12C (SEQ ID NO: 4).
- active variants of KRAS4A G12C are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 4.
- an active KRAS4A G12C variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 4.
- an active KRAS4A G12C variant comprises a C at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4A G12C (SEQ ID NO: 4) are provided and/or expressed.
- sequences encoding active variants of KRAS4A G12C are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4A G34T sequence SEQ ID NO: 3.
- sequences comprising at least 70% e.g., 70%, 75%, 80%,
- a KRAS4A G34T variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 3.
- a KRAS4A G34T variant nucleotide sequence comprises a T at position 34 of SEQ ID NO: 3.
- kits for enhanced target engagement comprising providing a KRAS4A G34T variant nucleotide sequence (e.g., a variant of SEQ ID NO: 3) that encodes and active KRAS4A G12C variant.
- a KRAS4A G34T variant nucleotide sequence e.g., a variant of SEQ ID NO: 3
- systems for enhanced target engagement comprising an active variant of KRAS4A G12D (SEQ ID NO: 6).
- active variants of KRAS4A G12D are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 6.
- an active KRAS4A G12D variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 6.
- an active KRAS4A G12D variant comprises a D at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4A G12D (SEQ ID NO: 6) are provided and/or expressed.
- systems for enhanced target engagement comprising a nucleic acid (e.g., variants of SEQ ID NO: 5) encoding an active variant of KRAS4A G12D .
- sequences encoding active variants of KRAS4A G12D are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4A G35A sequence SEQ ID NO: 5.
- sequences comprising at least 70% e.g., 70%, 75%, 80%,
- a KRAS4A G35A variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 5.
- a KRAS4A G35A variant nucleotide sequence comprises a A at position 35 of SEQ ID NO: 5.
- KRAS4A G35A variant nucleotide sequence e.g., a variant of SEQ ID NO: 5
- a variant of SEQ ID NO: 5 encodes and active KRAS4A G12D variant.
- systems for enhanced target engagement comprising an active variant of KRAS4A G12V (SEQ ID NO: 8).
- active variants of KRAS4A G12V are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 8.
- an active KRAS4A G12V variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 8.
- an active KRAS4A G12V variant comprises a V at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4A G12V (SEQ ID NO: 8) are provided and/or expressed.
- sequences encoding active variants of KRAS4A G12V are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4A G35T sequence SEQ ID NO: 7. In some embodiments, sequences comprising at least 70% (e.g., 70%, 75%, 80%,
- a KRAS4A G35T variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 7.
- a KRAS4A G35T variant nucleotide sequence comprises a T at position 35 of SEQ ID NO: 7.
- kits for enhanced target engagement comprising providing a KRAS4A G35T variant nucleotide sequence (e.g., a variant of SEQ ID NO: 5) that encodes and active KRAS4A G12V variant.
- a KRAS4A G35T variant nucleotide sequence e.g., a variant of SEQ ID NO: 5
- an active variant of KRAS4B (SEQ ID NO: 10).
- active variants of KRAS4B are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 10.
- an active KRAS4B variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 10.
- an active KRAS4B variant comprises a substitution at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4B (SEQ ID NO: 10) are provided and/or expressed.
- sequences encoding active variants of KRAS4B are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4B sequence SEQ ID NO:
- sequences comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 9 are provided.
- a KRAS4B variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 9.
- a KRAS4B variant nucleotide sequence comprises a substitution at one or more of positions 34, 35 or 36 of SEQ ID NO: 9.
- provided herein are methods of enhanced target engagement comprising providing a KRAS4B variant nucleotide sequence (e.g., a variant of SEQ ID NO: 1) that encodes and active KRAS4B variant.
- systems for enhanced target engagement comprising an active variant of KRAS4B G12C (SEQ ID NO: 12).
- active variants of KRAS4B G12C are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 12.
- an active KRAS4B G12C variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 12.
- an active KRAS4B G12C variant comprises a C at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4B G12C (SEQ ID NO: 12) are provided and/or expressed.
- sequences encoding active variants of KRAS4B G12C are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4B G34T sequence SEQ ID NO: 11.
- sequences comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 11 are provided.
- a KRAS4B G34T variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 11.
- a KRAS4B G34T variant nucleotide sequence comprises a T at position 34 of SEQ ID NO: 11.
- kits for enhanced target engagement comprising providing a KRAS4B G34T variant nucleotide sequence (e.g., a variant of SEQ ID NO: 11) that encodes and active KRAS4B G12C variant.
- a KRAS4B G34T variant nucleotide sequence e.g., a variant of SEQ ID NO: 11
- systems for enhanced target engagement comprising an active variant of KRAS4B G12D (SEQ ID NO: 14).
- active variants of KRAS4B G12D are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 14.
- an active KRAS4B G12D variant is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 14.
- an active KRAS4B G12D variant comprises a D at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4B G12D (SEQ ID NO: 14) are provided and/or expressed.
- sequences encoding active variants of KRAS4B G12D are provided, for example, sequences encoding active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with the KRAS4B G35A sequence SEQ ID NO: 13.
- sequences comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 13 are provided.
- a KRAS4B G35A variant nucleotide sequence is provided with one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 60, or ranges therebetween) relative to SEQ ID NO: 13.
- a KRAS4B G35A variant nucleotide sequence comprises aN A at position 35 of SEQ ID NO: 13.
- provided herein are methods of enhanced target engagement comprising providing a KRAS4B G35A variant nucleotide sequence (e.g., a variant of SEQ ID NO: 13) that encodes and active KRAS4B G12D variant.
- a KRAS4B G35A variant nucleotide sequence e.g., a variant of SEQ ID NO: 13
- an active variant of KRAS4B G12V (SEQ ID NO: 16).
- active variants of KRAS4B G12V are provided, for example, active variants (e.g., constitutively active) comprising at least 70% (e.g., 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100%, or ranges therebetween) sequence identity with SEQ ID NO: 16.
- an active KRAS4B G12V variant is provided with one or more substitutions (e.g.,
- an active KRAS4B G12V variant comprises a V at position 12.
- methods for enhanced target engagement comprising in which active variants of KRAS4B G12V (SEQ ID NO: 16) are provided and/or expressed.
- the kinase binding agent is general kinase inhibitor or a specific kinase inhibitor (e.g., a drug molecule that binds to and inhibits one or more kinases).
- exemplary kinase inhibitors that find use as kinase binding moieties in embodiments herein include , but are not limited to afatinib, nintedanib, crizotinib, alectinib, trametinib, cabozantinib, midostaurin, dabrafenib, sunitinib, ruxolitinib, vemurafenib , sorafenib, axitinib, lenvatinib, regorafenib, ponatinib, cabozantinib, brigatinib, avapritinib, erdafitinib, encorafenib, van
- kinase binding agents comprising a kinase binding moiety linked to a functional element, such as:
- a functional kinase binding agent comprises any ligand capable of binding (e.g., stably) to a kinase tethered to a functional element.
- a linker provides sufficient distance between the kinase binding moiety and the functional element (e.g., detectable element, capture element, affinity element, solid surface, etc.) to allow each to function undisturbed (or minimally disturbed by the linkage to the other.
- linkers provide sufficient distance to allow a kinase binding agent to bind a kinase and detectable moiety to be detectable (e.g., without or with minimal interference between the two).
- a linker separates a compound herein (e.g., CC-1852, CC-1861, CC- CTx-0294885, analogs or derivatives thereof (e.g., CC-1816, CC-1817, CC-1803, CC-1804, CC-1290, CC1294, etc.), etc.) and a detectable element (e.g., detectable element, solid surface, etc.) by 5 angstroms to 1000 angstroms, inclusive, in length.
- a detectable element e.g., detectable element, solid surface, etc.
- Suitable linkers separate a compound herein and a detectable element by 5 A, 10 A, 20 A, 50 A, 100 A, 150 A, 200 A, 300 A, 400 A, 500 A, 600 A, 700 A, 800 A, 900 A, 1000 A, and any suitable ranges therein (e.g., 5-100 A, 50-500 A, 150-700 A, etc.).
- the linker separates a compound herein and a detectable element by 1-200 atoms (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 200, or any suitable ranges therein (e.g., 2-20, 10-50, etc.)).
- a linker comprises 1 or more (e.g., 1-20 (e.g., 1, 2, 3,4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or any ranges therebetween) -(Cfh ⁇ O- (oxy ethylene) groups (e.g., -(CH2)20-(CH2)20-(CH2)20-(CH2)20-, -(CH2)20-(CH2)20- (CH 2 )20-(CH 2 )20- CH 2 ) 2 0-, -(CH 2 )20-(CH2)20-(CH2)20-(CH2)20-(CH 2 )20- CH 2 )20-(CH 2 )20-, etc ).
- the linker is -(CH2)20-(CH2)20-(CH2)20-(CH2)20-(CH2)20-.
- a linker is attached to a kinase binding moiety herein at the 4- position of a piperazine.
- the N at the 4-position of the piperazine of a kinase binding moiety forms an amide bond with the terminus of a linker.
- a linker comprises one or more (e.g., 2, 3, 4, 5, 6, or more or ranges therebetween) amides.
- a linker comprises two or more “linker moieties” (L 1 , L 2 , etc.).
- a linker comprises a cleavable (e.g., enzymatically cleavable, chemically cleavable, etc.) moiety (Y) and 0, 1, 2, of more “linker moieties” (L 1 , L 2 , etc.).
- linker moieties are straight or branched chains comprising any combination of alkyl, alkenyl, or alkynyl chains, and main-chain heteroatoms (e.g., O, S, N,
- a linker moiety comprises an alkyl carbamate group (e.g., (CH2)nOCONH, (CH2)nNHCOO, etc.).
- the alkyl carbamate is oriented such the COO end is oriented toward the kinase binding moiety and the NH end is oriented toward the functional element.
- the alkyl carbamate is oriented such the NH end is oriented toward the kinase binding moiety and the COO end is oriented toward the functional element.
- a linker or linker moiety comprises a single alkyl carbamate group.
- a linker or linker moiety comprises two or more alkyl carbamate groups (e.g., 2, 3, 4, 5, 6, 7, 8, etc.).
- a linker moiety comprises more than 1 linearly connected C, S, N, and/or O atoms. In some embodiments, a linker moiety comprises one or more alkyl carbamate groups. In some embodiments, a linker moiety comprises one or more alkyl groups (e.g., methyl, ethyl, propyl, butyl, pentyl, hexyl, etc.).
- a linker moiety comprises 1-200 linearly connected atoms (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 200, or any suitable ranges therein (e.g., 2-20, 10-50, 6-18)).
- a linker moiety is 1-200 linearly connected atoms (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120,
- 140, 160, 180, 200, or any suitable ranges therein e.g., 2-20, 10-50, 6-18) in length.
- functional kinase binding agents comprise a kinase binding moiety linked (e.g., directly or via a linker) to a functional element (e.g., detectable element, capture element, affinity element, solid surface, etc.).
- a functional element e.g., detectable element, capture element, affinity element, solid surface, etc.
- a functional kinase binding agent is biocompatible (e.g., cell compatible) and/or cell permeable. Therefore, in some embodiments, suitable functional elements (e.g., detectable elements, affinity elements, solid supports, capture elements) are ones that are cell compatible and/or cell permeable within the context of such compositions.
- a composition comprising an addition element when added extracellularly, is capable of crossing the cell membrane to enter a cell (e.g., via diffusion, endocytosis, active transport, passive transport, etc.).
- suitable functional elements and linkers are selected based on cell compatibility and/or cell permeability, in addition to their particular function.
- functional elements have a detectable property that allows for detection of the functional kinase binding agent and/or an analyte (e.g., kinase) bound thereto.
- Detectable elements include those with a characteristic electromagnetic spectral property such as emission or absorbance, magnetism, electron spin resonance, electrical capacitance, dielectric constant, or electrical conductivity as well as functional groups which are ferromagnetic, paramagnetic, diamagnetic, luminescent, electrochemiluminescent, fluorescent, phosphorescent, chromatic, antigenic, or have a distinctive mass.
- a detectable element includes, but is not limited to, a nucleic acid molecule (e.g., DNA or RNA (e.g., an oligonucleotide or nucleotide), a protein (e.g., a luminescent protein, a peptide, a contrast agent (e.g., MRI contract agent), a radionuclide, an affinity tag (e.g., biotin or streptavidin), a hapten, an amino acid, a lipid, a lipid bilayer, a solid support, a fluorophore, a chromophore, a reporter molecule, a radionuclide, an electron opaque molecule, a MRI contrast agent (e.g., manganese, gadolinium(III), or iron-oxide particles), or a coordinator thereof, and the like.
- a nucleic acid molecule e.g., DNA or RNA (e.g., an oligonucleotide
- a functional element is or comprises a solid support.
- Suitable solid supports include a sedimental particle such as a magnetic particle, a sepharose, or cellulose bead; a membrane; glass, e.g., glass slides; cellulose, alginate, plastic, or other synthetically prepared polymer (e.g., an Eppendorf tube or a well of a multi-well plate); self- assembled monolayers; a surface plasmon resonance chip; or a solid support with an electron conducting surface; etc.
- Exemplary functional elements include haptens (e.g., molecules useful to enhance immunogenicity such as keyhole limpet hemacyanin), cleavable labels (e.g., photocleavable biotin) and fluorescent labels (e.g., N-hydroxysuccinimide (NHS) modified coumarin and succinimide or sulfonosuccinimide modified BODIPY (which can be detected by UV and/or visible excited fluorescence detection), rhodamine (R110, rhodols, CRG6, Texas Methyl Red (TAMRA), Rox5, FAM, or fluorescein), coumarin derivatives (e.g., 7 aminocoumarin, and 7- hydroxy coumarin, 2-amino-4-methoxynapthalene, 1-hydroxypyrene, resorufm, phenalenones or benzphenalenones (U.S.
- haptens e.g., molecules useful to enhance immunogenicity
- acridinones U.S. Pat. No. 4,810,636
- anthracenes and derivatives of alpha and beta-naphthol
- fluorinated xanthene derivatives including fluorinated fluoresceins and rhodols
- bioluminescent molecules e.g., luciferase (e.g., Oplophorus-derive luciferase (See e.g., U.S. App. Ser. No. 12/773,002; U.S. App. Ser. No.
- a fluorescent (or bioluminescent) detectable element may be used to sense changes in a system, like phosphorylation, in real-time.
- a fluorescent molecule such as a chemosensor of metal ions, may be employed to label proteins which bind the composition.
- a bioluminescent or fluorescent functional group such as BODIPY, rhodamine green, GFP, or infrared dyes, finds use as a detectable element and may, for instance, be employed in interaction studies (e.g., using BRET, FRET, LRET or electrophoresis).
- detectable elements includes molecules detectable using electromagnetic radiation and includes, but is not limited to, xanthene fluorophores, dansyl fluorophores, coumarins and coumarin derivatives, fluorescent acridinium moieties, benzopyrene-based fluorophores as well as 7-nitrobenz-2-oxa-l, 3-diazole, and 3-N-(7- nitrobenz-2-oxa-l,3-diazol-4-yl)-2, 3-diamino-propionic acid.
- the fluorescent molecule has a high quantum yield of fluorescence at a wavelength different from native amino acids and more preferably has high quantum yield of fluorescence that can be excited in the visible, or in both the UV and visible, portion of the spectrum.
- the molecule Upon excitation at a preselected wavelength, the molecule is detectable at low concentrations either visually or using conventional fluorescence detection methods.
- Electrochemiluminescent molecules such as ruthenium chelates and its derivatives or nitroxide amino acids and their derivatives are detectable at femtomolar ranges and below.
- a detectable element is a fluorophore.
- Suitable fluorophores for linking to a kinase binding moiety include, but are not limited to: xanthene derivatives (e.g., fluorescein, rhodamine, Oregon green, eosin, Texas red, etc.), cyanine derivatives (e.g., cyanine, indocarbocyanine, oxacarbocyanine, thiacarbocyanine, merocyanine, etc.), naphthalene derivatives (e.g., dansyl and prodan derivatives), oxadiazole derivatives (e.g., pyridyloxazole, nitrobenzoxadiazole, benzoxadiazole, etc.), pyrene derivatives (e.g., cascade blue), oxazine derivatives (e.g., Nile red, Nile blue, cre
- a fluorophore is a rhodamine analog (e.g., carboxy rhodamine analog) such as those described in U.S. Pat. App. Ser. No. 13/682,589, herein incorporated by reference in its entirety.
- a functional element is a capture element.
- a capture element is a substrate for a protein (e.g., enzyme), and the capture agent is that protein.
- a capture element is a “covalent substrate” or one that forms a covalent bond with a protein or enzyme that it reacts with.
- the substrate may comprise a reactive group (e.g., a modified substrate) that forms a covalent bond with the enzyme upon interaction with the enzyme, or the enzyme may be a mutant version that is unable to reconcile a covalently bound intermediate with the substrate.
- the substrate is recognized by a mutant protein (e.g., mutant dehalogenase), which forms a covalent bond thereto.
- the substrate may be any suitable substrate for any mutant protein that has been altered to form an ultra-stable or covalent bond with its substrate that would ordinarily only transiently bound by the protein.
- the protein is a mutant hydrolase or dehalogenase. In some embodiments, the protein is a mutant dehalogenase and the substrate is a haloalkane.
- the haloalkane comprises an alkane (e.g., C2-C20) capped by a terminal halogen (e.g., Cl, Br, F, I, etc.).
- the haloalkane is of the formula A-X, wherein X is a halogen (e.g., Cl, Br, F, I, etc.), and wherein A is an alkane comprising 2-20 carbons.
- A comprises a straight-chain segment of 2-12 carbons. In certain embodiments, A is a straight-chain segment of 2-12 carbons. In some embodiments, the haloalkane may comprise any additional pendants or substitutions that do not interfere with interaction with the mutant dehalogenase.
- a capture agent is a SNAP-Tag and a capture element is benzyl guanine (See, e.g., Crivat G, Taraska JW (January 2012). Trends in Biotechnology 30 (1): 8- 16.; herein incorporated by reference in its entirety).
- a capture agent is a CLIP-Tag and a capture element is benzyl cytosine (See, e.g., Gautier, et al. Chem Biol. 2008 Feb;15(2): 128-36.; herein incorporated by reference in its entirety).
- mutant proteins e.g., mutant hydrolases (e.g., mutant dehalogenases) that covalently bind their substrates (e.g., haloalkane substrates) are described, for example, in U.S. Pat. No. 7,238,842; U.S. Pat. No. 7,425,436; U.S. Pat. No. 7,429,472; U.S. Pat. No. 7,867,726; each of which is herein incorporated by reference in their entireties.
- a functional element of a functional kinase binding agent is an affinity element (e.g., that binds to an affinity agent).
- affinity molecules include molecules such as immunogenic molecules (e.g., epitopes of proteins, peptides, carbohydrates, or lipids (e.g., any molecule which is useful to prepare antibodies specific for that molecule)); biotin, avidin, streptavidin, and derivatives thereof; metal binding molecules; and fragments and combinations of these molecules.
- Exemplary affinity molecules include 5x His (HHHHH)(SEQ ID NO: 19), 6x His (HHHHHH)(SEQ ID NO: 20), C-myc (EQKLISEEDL) (SEQ ID NO: 21), Flag (DYKDDDDK) (SEQ ID NO: 22), SteptTag (WSHPQFEK)(SEQ ID NO: 23), HA Tag (YPYDVPDYA) (SEQ ID NO: 24), thioredoxin, cellulose binding domain, chitin binding domain, S -peptide, T7 peptide, calmodulin binding peptide, C-end RNA tag, metal binding domains, metal binding reactive groups, amino acid reactive groups, inteins, biotin, streptavidin, and maltose binding protein.
- dansyllysine Another example of an affinity molecule is dansyllysine.
- Antibodies that interact with the dansyl ring are commercially available (Sigma Chemical; St. Louis, Mo.) or can be prepared using known protocols such as described in Antibodies: A Laboratory Manual (Harlow and Lane, 1988).
- Embodiments herein find use in the engagement of various kinases with a functional kinase binding agent.
- kinases are expressed endogenously in a sample (e.g., cell, cell lysate, cell-free system, tissue, organism, etc.).
- kinases are expressed from a suitable genetic and/or viral vector (e.g., a vector introduced into the sample (e.g., cell)).
- viral vectors include, without limitation, vectors based on DNA or RNA viruses, such as adenovirus, adeno-associated virus (AAV), retroviruses, lentiviruses, vaccinia virus, measles viruses, herpes viruses, baculoviruses, and papilloma virus vectors. See, Kay et ak, Proc. Natl.
- kinases are expressed/provided as a fusion and/or with a tag for detection, identification, etc. In some embodiments, kinases are expressed/provided as a fusion with a bioluminescent reporter. In some embodiments, kinases are expressed/provided as a fusion with a luciferase.
- kinases are expressed/provided as a fusion with an active variant of an Oplophorus luciferase.
- provided herein kinases a provided/expressed as fusions with bioluminescent polypeptides and/or components of bioluminescent complexes based on (e.g., structurally, functionally, etc.) the luciferase of Oplophorus gracilirostris, the NanoLuc® luciferase (Promega Corporation;
- NanoBiT U.S. Pat. No. 9,797,889; herein incorporated by reference in its entirety
- orNanoTrip U.S. Pat. Appln. Serial No. 16/439,565; and U.S. Prov. Appln. Serial No. 62/941,255; both of which are herein incorporated by reference in their entireties.
- methods and systems herein incorporate commercially available NanoLuc®-based technologies (e.g., NanoLuc® luciferase, NanoBRET, NanoBiT,
- NanoTrip NanoTrip, NanoGlo, etc.
- various combinations, variations, or derivations from the commercially available NanoLuc®-based technologies are employed.
- kinases are expressed/provided as a fusion with a bioluminescent polypeptide including but not limited to NanoLuc® and/or the bioluminescent polypeptides described in PCT Appln. No. PCT/US2010/033449, U.S. Patent No. 8,557,970, PCT Appln. No. PCT/2011/059018, and U.S. Patent No. 8,669,103 (each of which is herein incorporated by reference in their entirety and for all purposes).
- bioluminescent polypeptides are linked (e.g., fused, chemically linked, etc.) to a kinase for use in the methods and systems described herein.
- kinases are expressed/provided as a fusion with a component of a bioluminescent complex, including but not limited to NanoBiT®, NanoTrip, and/or the peptide and polypeptide components of bioluminescent complexes described in, for example, PCT Appln. No. PCT/US 14/26354; U.S. Patent No. 9,797,889; U.S. Pat. Appln. Serial No. 16/439,565 (PCT/US2019/036844); and U.S. Prov. Appln. Serial No. 62/941,255 (each of which is herein incorporated by reference in their entirety and for all purposes).
- such peptide and/or polypeptide components of bioluminescent complexes are linked (e.g., fused, chemically linked, etc.) to a kinase for use in the methods and systems described herein.
- a protein e.g., kinase
- a bioluminescent reporter e.g., luciferase, component of the bioluminescent complex, etc.
- BRET bioluminescence resonance energy transfer
- systems comprising kinases fused to bioluminescent reporters (e.g., NanoLuc®-based reporters) and functional kinase binding agents comprising an energy acceptor (e.g., a fluorophore) as the detectable element, wherein the emission spectrum of the bioluminescent reporter and the excitation spectrum of the fluorophore overlap, such that engagement (e.g., binding) of the functional kinase binding agent with to the kinase can be detected by an increase (e.g., the presence of) BRET between the bioluminescent reporter and the energy acceptor (e.g., a fluorophore).
- bioluminescent reporters e.g., NanoLuc®-based reporters
- functional kinase binding agents comprising an energy acceptor (e.g., a fluorophore) as the detectable element, wherein the emission spectrum of the bioluminescent reporter and the excitation spectrum of the fluorophore overlap, such that engagement (e.g., binding)
- any of the NanoLuc®-based, NanoBiT-based, and/or NanoTrip-based peptides, polypeptide, complexes, fusions, and conjugates may find use in BRET-based applications with the systems and methods described herein.
- a kinase (or kinases) are fused to a bioluminescent reported (e.g., NanoLuc®-based, NanoBiT-based, and/or NanoTrip-based polypeptide, peptide, or complex), and a functional kinase binding agent comprising an energy acceptor (e.g., a fluorophore (e.g., fluorescent protein, small molecule fluorophore, etc.)), wherein the emission spectrum of the NanoLuc®-based, NanoBiT-based, and/or NanoTrip-based polypeptide, peptide, or complex overlaps the excitation spectrum of the energy acceptor (e.g., a fluorophore).
- a fluorophore e.g., fluorescent protein, small molecule fluorophore, etc.
- BRET is detected upon engagement of the functional kinase binding agent with the kinase, and in the presence of a substrate (e.g., coelenterazine, furimazine, etc.) for the bioluminescent reporter.
- a substrate e.g., coelenterazine, furimazine, etc.
- an energy acceptor refers to any small molecule (e.g., chromophore), macromolecule (e.g., autofluorescent protein, phycobiliproteins, nanoparticle, surface, etc.), or molecular complex that produces a readily detectable signal in response to energy absorption (e.g., resonance energy transfer).
- an energy acceptor is a fluorophore or other detectable chromophore.
- Suitable fluorophores include, but are not limited to: xanthene derivatives (e.g., fluorescein, rhodamine, Oregon green, eosin, Texas red, etc.), cyanine derivatives (e.g., cyanine, indocarbocyanine, oxacarbocyanine, thiacarbocyanine, merocyanine, etc.), naphthalene derivatives (e.g., dansyl and prodan derivatives), oxadiazole derivatives (e.g., pyridyloxazole, nitrobenzoxadiazole, benzoxadiazole, etc.), pyrene derivatives (e.g., cascade blue), oxazine derivatives (e.g., Nile red, Nile blue, cresyl violet, oxazine 170, etc.), acridine derivatives (e.g., proflavin, acridine orange, acrid
- a fluorophore is a rhodamine analog (e.g., carboxy rhodamine analog), such as those described in U.S. Pat. App. Ser. No. 13/682,589, herein incorporated by reference in its entirety.
- the systems and methods herein find use with a broad spectrum of kinases, including protein kinases are of the following common families or subgroups: AGC (e.g., containing the PKA, PKG and PKC subfamilies), CAMK (e.g., calcium/calmodulin-dependent protein kinases), CK1 (e.g., casein kinase 1), CMGC (e.g., containing the CDK, MAPK, GSK3 and CLK subfamilies), NEK, RGC (e.g., receptor guanylate cyclases), STE, TKL (e.g., tyrosine protein kinase-like), and Tyr (e.g., tyrosine protein kinase).
- AGC e.g., containing the PKA, PKG and PKC subfamilies
- CAMK e.g., calcium/calmodulin-dependent protein kinases
- CK1 e.g
- the functional kinase binding agents herein bind to one or more kinases of atypical kinase families, such as, ADCK, alpha-type, FAST, PDK/BCKDK, PI3/PI4-kinase, RIO-type, etc.
- the functional kinase binding agents herein bind to kinases of any suitable organism.
- systems and methods herein find use with human and/or mouse kinases, such as those listed in Tables 1 A-O, and/or homologs and analogs from other organisms.
- AKT1 AKT 1 HUMAN P31749
- AKT1 MOUSE P31750
- AKT2 AKT2 HUMAN P31751
- AKT2 MOUSE Q60823
- GRK2 ARBKl HUMAN P25098
- ARBKl MOUSE Q99MK8
- GRK3 ARBK2 HUMAN P35626)
- ARBK2 MOUSE Q3UYH7
- GRK4 GRK4 HUMAN P32298)
- GRK4 MOUSE (070291)
- MAST1 MAST 1 HUMAN (Q9Y2H9) MAST1 MOUSE (Q9R1L5) MAST2 MAST2 HUMAN (Q6P0Q8) MAST2 MOUSE (Q60592) MAST3 MAST3 HUMAN (060307) MAST3 MOUSE (Q3U214) MAST4 MAST4 HUMAN (015021) MAST4 MOUSE (Q811L6) MASTL GWL HUMAN (Q96GX5) GWL MOUSE (Q8C0P0)
- PRKACA KAPCA HUMAN PI 7612
- KAPC A MOUSE P05132
- PRKACB KAPCB HUMAN P22694
- KAPCB MOUSE P68181
- PRKACG KAPCG HUMAN P22612
- PRKCD KPCD HUMAN Q05655
- KPCD MOUSE P28867
- PRKCE KPCE HUMAN Q02156
- KPCE MOUSE P16054
- PRKX PRKX HUMAN P51817) PRKX MOUSE (Q922R0)
- ROCK1 ROCK1 HUMAN (Q 13464) ROCK1 MOUSE (P70335) ROCK2 ROCK2 HUMAN (075116) ROCK2 MOUSE (P70336) RPS6KA1 KS6A1_HUMAN (Q15418) KS6A1 MOUSE (P18653) RPS6KA2 KS6A2_HUMAN (Q15349) KS6A2 MOUSE (Q9WUT3) RPS6KA3 KS6A3 HUMAN (P51812) KS6A3 MOUSE (P18654) RPS6KA4 KS 6 A4 HUM AN (075676) KS6A4 MOUSE (Q9Z2B9) RPS6KA5 KS 6 A5 HUM AN (075582) KS6A5 MOUSE (Q8C050) RPS6KA6 KS 6 A6 HUMAN (Q9UK32) KS6A6 MOUSE (Q7TPS0) RPS6KB1 KS 6B 1 HUMAN (P23443)
- DAPK1 DAPK1 HUMAN P53355) DAPK1 MOUSE (Q80YE7) DAPK2 DAPK2 HUMAN (Q9UIK4) DAPK2 MOUSE (Q8VDF3) DAPK3 DAPK3 HUMAN (043293) DAPK3 MOUSE (054784) DCLK1 DCLK1 HUMAN (015075) DCLK1 MOUSE (Q9JLM8) DCLK2 DCLK2 HUMAN (Q8N568) DCLK2 MOUSE (Q6PGN3) DCLK3 DCLK3 HUMAN (Q9C098) DCLK3 MOUSE (Q8BWQ5) Gm4922 SMKZ_MOUSE (Q8C0N0)
- NUAK1 NUAK1 HUMAN (060285) NUAK1 MOUSE (Q641K5) NUAK2 NUAK2 HUMAN (Q9H093) NUAK2 MOUSE (Q8BZN4) OBSCN OB S CN HUM AN (Q5VST9) OBSCN MOUSE (A2AAJ9) PASK PASK HUMAN (Q96RG2) PASK MOUSE (Q8CEE6)
- SIK1 SIK1 HUMAN P57059
- SIK1 MOUSE Q60670
- SIK2 SIK2 HUMAN Q9H0K1
- SIK2 MOUSE Q8CFH6
- SIK3 SIK3 HUMAN Q9Y2K2 SIK3 MOUSE (Q6P4S6)
- SNRK SNRK HUMAN (Q9NRH2) SNRK MOUSE (Q8VDU5) SPEG SPEG HUMAN (Q15772) SPEG MOUSE (Q62407) STK11 STK11 HUMAN (Q 15831) STK11 MOUSE (Q9WTK7) STK17A ST17A HUMAN (Q9UEE5)
- STK17B ST17B HUMAN (094768) ST17B MOUSE (Q8BG48) STK33 STK33 HUMAN (Q9BYT3) STK33 MOUSE (Q924X7) STK40 STK40 HUMAN (Q8N2I9) STK40 MOUSE (Q7TNL3) Smok2a SMK2A_MOUSE (Q9QYZ6)
- TRIB1 TRIBI HUMAN Q96RU8 TRIBI MOUSE (Q8K4K4) TRIB2 TRIB2 HUMAN (Q92519) TRIB2 MOUSE (Q8K4K3) TRIB3 TRIB3 HUMAN (Q96RU7) TRIB3 MOUSE (Q8K4K2) TRIO TRIO HUMAN (075962) TRIO MOUSE (Q0KL02) TSSK1B TS SKI HUMAN (Q9BXA7) TS SKI MOUSE (Q61241) TSSK2 TS SK2 HUMAN (Q96PF2) TSSK2 MOUSE (054863)
- TSSK3 TSSK3 HUMAN Q96PN8 TSSK3 MOUSE (Q9D2E1) TSSK4 TSSK4 HUMAN (Q6SA08) TSSK4 MOUSE (Q9D411) TSSK6 TS SK6 HUMAN (Q9BXA6) TSSK6 MOUSE (Q925K9)
- TTN TITIN HUMAN Q8WZ42
- A2ASS6 TTN TITIN MOUSE
- CSNK1A1 KC 1 A HUM AN (P48729) KC1A MOUSE (Q8BK63) CSNK1A1L KC 1 AL HUMAN (Q8N752)
- CSNK1D KC1D HUMAN P48730) KC1D MOUSE (Q9DC28) CSNK1E KC1E HUMAN (P49674) KC1E MOUSE (Q9JMK2) CSNK1G1 KC1G1 HUMAN (Q9HCP0) KC1G1 MOUSE (Q8BTH8) CSNK1G2 KC1G2 HUMAN (P78368) KC1G2 MOUSE (Q8BVP5) CSNK1G3 KC1G3 HUMAN (Q9Y6M4) KC1G3 MOUSE (Q8C4X2) TTBK1 TTBK1 HUMAN (Q5TCY1) TTBK1 MOUSE (Q6PCN3) TTBK2 TTBK2 HUMAN (Q6IQ55) TTBK2 MOUSE (Q3UVR3) VRK1 VRK1 HUMAN (Q99986) VRK1 MOUSE (Q80X41) VRK2 VRK2 HUMAN (Q
- CDK1 CDK1 HUMAN P06493
- CDK1 MOUSE PI 1440
- CDK10 CDK10 HUMAN Q 15131
- CDK10 MOUSE Q3UMM4
- CDK11A CD11 A HUMAN Q9UQ88
- CDKL1 CDKL 1 HUMAN (Q00532) CDKL1 MOUSE (Q8CEQ0) CDKL2 CDKL2 HUMAN (Q92772) CDKL2 MOUSE (Q9QUK0) CDKL3 CDKL3 HUMAN (Q8IVW4) CDKL3 MOUSE (Q8BLF2) CDKL4 CDKL4 HUMAN (Q5MAI5) CDKL4 MOUSE (Q3TZA2) CDKL5 CDKL5 HUMAN (076039) CDKL5 MOUSE (Q3UTQ8) CLK1 CLK1 HUMAN (P49759) CLK1 MOUSE (P22518)
- MAK MAK HUMAN P20794
- MAK MOUSE Q04859
- MAPK1 MKO 1 HUMAN P28482) MKOI MOUSE
- P63085 MAPK10 MK10 HUMAN (P53779) MKIO MOUSE (Q61831)
- MAPK11 MK11 HUMAN Q15759
- MK11 M0USE Q9WUI1
- MAPK12 MK12 HUMAN P53778)
- MK12 MOUSE 008911
- MAPK13 MK13 HUMAN (015264) MK13 MOUSE (Q9Z1B7)
- MAPK14 MK14 HUMAN Q16539
- MK14 MOUSE P47811)
- MAPK15 MK15 HUMAN Q8TD08
- MK15 MOUSE Q80Y86
- MAPK8 MK08 HUMAN P45983 MK08 MOUSE (Q91Y86) MAPK9 MK09 HUMAN (P45984) MK09 MOUSE (Q9WTU6) MOK MOK HUMAN (Q9UQ07) MOK MOUSE (Q9WVS4) NLK NLK HUMAN (Q9UBE8) NLK MOUSE (054949) PRPF4B PRP4B HUMAN (Q 13523) PRP4B MOUSE (Q61136) SRPK1 SRPK1 HUMAN (Q96SB4) SRPK1 MOUSE (070551) SRPK2 SRPK2 HUMAN (P78362) SRPK2 MOUSE (054781) SRPK3 SRPK3 HUMAN (Q9UPE1) SRPK3 MOUSE (Q9Z0G2)
- NEK1 NEK1 HUMAN Q96PY6
- NEK1 MOUSE P51954
- NEK10 NEK10 HUMAN Q6ZWH5
- NEKIO MOUSE Q3UGM2
- NEK11 NEK11 HUMAN Q8NG66
- NEK11 M0USE Q8C0Q4
- NEK2 NEK2 HUMAN P51955)
- NEK3 NEK3 HUMAN P51956
- NEK3 M0USE Q9R0A5
- NEK4 NEK4 HUMAN P51957
- NEK4 M0USE Q9Z1J2
- NEK5 NEK5 HUMAN Q6P3R8 NEK5 M0USE (Q7TSC3) NEK6 NEK6 HUMAN (Q9HC98) NEK6 M0USE (Q9ES70) NEK7 NEK7 HUMAN (Q8TDX7) NEK7 M0USE (Q9ES74) NEK8 NEK8 HUMAN (Q86SG6) NEK8 M0USE (Q91ZR4) NEK9 NEK9 HUMAN (Q8TD19) NEK9 M0USE (Q8K1R7)
- MAP2K1 MP2K1 HUMAN (Q02750) MP2K1 M0USE (P31938) MAP2K2 MP2K2 HUMAN (P36507) MP2K2 MOUSE (Q63932) MAP2K3 MP2K3 HUMAN (P46734) MP2K3 MOUSE (009110) MAP2K4 MP2K4 HUMAN (P45985) MP2K4 MOUSE (P47809) MAP2K5 MP2K5 HUMAN (Q13163) MP2K5 MOUSE (Q9WVS7) MAP2K6 MP2K6 HUMAN (P52564) MP2K6 MOUSE (P70236) MAP2K7 MP2K7 HUMAN (014733) MP2K7 MOUSE (Q8CE90) MAP3K1 M3K1 HUMAN (Q13233) M3K1 MOUSE (P53349) MAP3K10 M3K10_HUMAN (Q02779) M3K10_MOUSE (Q66L42
- OXSR1 OXSR1 HUMAN (095747) OXSR1 MOUSE (Q6P9R2) PAK1 PAK1 HUMAN (Q13153) PAK1 MOUSE (088643)
- PAK2 PAK2 HUMAN Q13177
- PAK2 MOUSE Q8CIN4
- PAK3 PAK3 HUMAN (075914)
- PAK3 MOUSE (Q61036)
- PAK5 PAK5 HUMAN Q9P286)
- PAK5 MOUSE Q8C015
- PAK6 PAK6 HUMAN (Q9NQU5) PAK6 MOUSE (Q3ULB5) PBK T OPK HUM AN (Q96KB5) TOPK MOUSE (Q9JJ78)
- STK10 STK10_HUMAN (094804) STK10_MOUSE (055098) STK24 STK24 HUMAN (Q9Y6E0) STK24 MOUSE (Q99KH8) STK25 STK25 HUMAN (000506) STK25 MOUSE (Q9Z2W1) STK26 STK26 HUMAN (Q9P289) STK26 MOUSE (Q99JT2)
- STK39 STK39 HUMAN (Q9UEW8) STK39 MOUSE (Q9Z1W9) STK4 STK4 HUMAN (Q13043) STK4 MOUSE (Q9JI11) STRADA STRAA HUMAN (Q7RTN6) STRAA MOUSE (Q3UUJ4) STRADB STRAB HUMAN (Q9C0K7) STRAB MOUSE (Q8K4T3) TAOK1 TAOK1 HUMAN (Q7L7X3) TAOK1 MOUSE (Q5F2E8) TAOK2 T AOK2 HUM AN (Q9UL54) TAOK2 MOUSE (Q6ZQ29) TAOK3 T AOK3 HUM AN (Q9H2K8) TAOK3 MOUSE (Q8BYC6) TNIK TNIK HUMAN (Q9UKE5) TNIK MOUSE (P83510)
- ACVR1 ACVR1 HUMAN (Q04771) ACVR1 MOUSE (P37172) ACVR1B AC V 1 B HUM AN (P36896) ACV1B MOUSE (Q61271) ACVR1C ACV1C HUMAN (Q8NER5) ACV1C MOUSE (Q8K348) ACVR2A AVR2A HUMAN (P27037) AVR2A MOUSE (P27038) ACVR2B AVR2B HUMAN (Q 13705) AVR2B MOUSE (P27040) ACVRLl AC VL 1 HUMAN (P37023) ACVL1 MOUSE (Q61288) AMHR2 AMHR2 HUMAN (Q 16671) AMHR2 MOUSE (Q8K592) ANKK1 ANKK1 HUMAN (Q8NFD2) ANKK1 MOUSE (Q8BZ25) ARAF ARAF HUMAN (PI 0398) ARAF MOUSE (P04627) BMPR1A BMR1 A HUMAN (P36894)
- IRAKI IRAKI HUMAN (P51617) IRAKI MOUSE (Q62406) IRAK2 IRAK2 HUMAN (043187) IRAK2 MOUSE (Q8CFA1) IRAK3 IRAK3 HUMAN (Q9Y616) IRAK3 MOUSE (Q8K4B2) IRAK4 IRAK4 HUMAN (Q9NWZ3) IRAK4 MOUSE (Q8R4K2) KSR1 KSR1 HUMAN (Q8IVT5) KSR1 MOUSE (Q61097) KSR2 KSR2 HUMAN (Q6VAB6) KSR2 MOUSE (Q3UVC0) LIMK1 LIMK1 HUMAN (P53667) LIMK1 MOUSE (P53668) LIMK2 LIMK2 HUMAN (P53671) LIMK2 MOUSE (054785) LRRKl LRRKI HUMAN (Q38SD2) LRRKl MOUSE (Q3UHC2) LRRK2 LRRK2
- AATK LMTK1 HUMAN Q6ZMQ8 LMTK1 MOUSE (Q80YE4) ABLl ABL1 HUMAN (P00519) ABL1 MOUSE (P00520)
- ABL2 ABL2 HUMAN P42684
- ABL2 MOUSE Q4JIM5
- ALK ALK HUMAN Q9UM73
- ALK MOUSE P97793
- EPHA1 EPHA1 HUMAN P21709
- EPHA1 MOUSE EPHA10 EPHAA HUMAN (Q5JZY3) EPHAA MOUSE (Q8BYG9)
- EPHA2 EPHA2 HUMAN P29317)
- EPHA2 MOUSE Q03145)
- EPHA3 EPHA3 HUMAN P29320
- EPHA3 MOUSE P29319)
- EPHA4 EPHA4 HUMAN P54764)
- EPHA4 MOUSE Q03137) EPHA5 EPHA5 HUMAN (P54756)
- EPHA5 MOUSE Q60629)
- EPHA6 EPHA6 HUMAN Q9UF33
- EPHA6 MOUSE Q62413) EPHA7 EPHA7 HUMAN (Q15375) EPHA7 MOUSE (Q61772)
- EPHA8 EPHA8 HUMAN P29322)
- EPHA8 MOUSE (009127)
- EPHB1 EPHB1 HUMAN P
- IGF1R IGF1R HUMAN P08069) IGF1R MOUSE (Q60751)
- JAK1 JAK1 HUMAN P23458 JAK1 MOUSE (P52332)
- JAK2 JAK2 HUMAN (060674) JAK2 MOUSE (Q62120)
- JAK3 JAK3 HUMAN P52333
- JAK3 MOUSE Q62137
- LMTK2 LMTK2 HUMAN Q8IWU2 LMTK2 MOUSE (Q3TYD6) LMTK3 LMTK3 HUMAN (Q96Q04) LMTK3 MOUSE (Q5XJV6) LTK LTK HUMAN (P29376) LTK MOUSE (P08923)
- MATK MATK HUMAN (P42679) MATK MOUSE (P41242) MERTK MERTK HUMAN (Q 12866) MERTK MOUSE (Q60805) MET MET HUMAN (P08581) MET MOUSE (P16056)
- ROS1 RO SI HUMAN P08922
- ROS1 MOUSE Q78DX7
- RYK RYK HUMAN P34925
- RYK MOUSE Q01887
- SRMS SRMS HUMAN Q9H3Y6
- SRMS MOUSE Q62270
- STYK1 STYK1 HUMAN Q6J9G0
- STYK1 MOUSE Q6J9G1
- SYK KSYK HUMAN P43405
- KSYK MOUSE P48025
- Smokl SMOK1 MOUSE Q9QYZ4
- TNK1 TNK1 HUMAN (Q13470) TNK1 MOUSE (Q99ML2) TNK2 ACK1 HUMAN (Q07912) ACK1 MOUSE (054967) TXK TXK HUMAN (P42681) TXK MOUSE (P42682) TYK2 TYK2 HUMAN (P29597) TYK2 MOUSE (Q9R117) TYR03 TYR03 HUMAN (Q06418) TYR03 M0USE (P55144) YES1 YES HUMAN (P07947) YES_MOUSE (Q04736) ZAP70 Z AP70 HUMAN (P43403) ZAP70_MOUSE (P43404)
- AAK1 AAK1 HUMAN Q2M2I8 AAK1 MOUSE (Q3UHJ0) AURKA AURKA HUMAN (014965) AURKA MOUSE (P97477) AURKB AURKB HUMAN (Q96GD4) AURKB MOUSE (070126) AURKC AURKC HUMAN (Q9UQB9) AURKC MOUSE (088445) BMP2K BMP2K HUMAN (Q9NSY1) BMP2K MOUSE (Q91Z96) BUB1 BUB1 HUMAN (043683) BUB1 MOUSE (008901)
- NRBP1 NRBP HUMAN Q9UHY1 NRBP MOUSE (Q99J45) NRBP2 NRBP2 HUMAN (Q9NSY0) NRBP2 MOUSE (Q91V36) PAN3 PAN3 HUMAN (Q58A45) PAN3 MOUSE (Q640Q5) PDIK1L PDK1 L HUMAN (Q8N165) PDK1L MOUSE (Q8QZR7) PEAK1 PEAK1 HUMAN (Q9H792) PEAK1 MOUSE (Q69Z38) PIK3R4 PI3R4 HUMAN (Q99570) PI3R4 MOUSE (Q8VD65)
- PINK1 PINK1 HUMAN (Q9BXM7) PINK1 MOUSE (Q99MQ3) PKDCC PKDCC HUMAN (Q504Y2) PKDCC MOUSE (Q5RJI4) PKMYT1 PMYT1 HUMAN (Q99640) PMYT1 MOUSE (Q9ESG9) PLK1 PLK1 HUMAN (P53350) PLK1 MOUSE (Q07832)
- PLK5 PLK5 HUMAN Q496M5
- PLK5 MOUSE Q4FZD7
- POMK SG196 HUMAN Q9H5K3
- PRAG1 PRAG1 HUMAN (Q86YV5) PRAG1 MOUSE (Q571I4) PXK PXK HUMAN (Q7Z7A4) PXK MOUSE (Q8BX57) RNASEL RN5A HUMAN (Q05823) RN5A MOUSE (Q05921) RPS6KC1 KS6C1 HUMAN (Q96S38) KS6C1 MOUSE (Q8BLK9) RPS6KL1 RPKLI HUMAN (Q9Y6S9) RPKL1 MOUSE (Q8R2S1) SBK1 SBK1 HUMAN (Q52WX2) SBK1 MOUSE (Q8QZX0) SBK2 SBK2 HUMAN (P0C263) SBK2 MOUSE (P0C5K1)
- SBK3 SBK3 HUMAN (P0C264) SBK3 MOUSE (P0C5K0) SCYL1 S C YL 1 HUMAN (Q96KG9) SCYL1 MOUSE (Q9EQC5) SCYL2 S C YL2 HUM AN (Q6P3W7) SCYL2 MOUSE (Q8CFE4) SCYL3 PACE 1 HUMAN (Q8IZE3) PACE1 MOUSE (Q9DBQ7) SGK494 SG494 HUMAN (Q96LW2) SG494 MOUSE (Q5SYL1)
- STK32A S T32 A HUM AN (Q8WU08) ST32A MOUSE (Q8BGW6) STK32B ST32B HUMAN (Q9NY57) ST32B MOUSE (Q9JJX8) STK32C ST32C HUMAN (Q86UX6) ST32C MOUSE (Q8QZV4) STK35 STK35 HUMAN (Q8TDR2) STK35 MOUSE (Q80ZW0) STK36 STK36 HUMAN (Q9NRP7) STK36 MOUSE (Q69ZM6) STKLD1 STKL 1 HUMAN (Q8NE28) STKL1 MOUSE (Q80YS9) TBCK TBCK HUMAN (Q8TEA7) TBCK MOUSE (Q8BM85) TBK1 TBK1 HUMAN (Q9UHD2) TBK1 MOUSE (Q9WUN2) TEX 14 TEX 14 HUM AN (Q8IWB6) TEX14 MOUSE (Q7M6U
- TLK2 TLK2 HUMAN (Q86UE8) TLK2 MOUSE (055047)
- UHMK1 UHMK1 HUMAN (Q8TAS1) UHMK1 MOUSE (P97343) ULK1 ULK1 HUMAN (075385) ULK1 MOUSE (070405) ULK2 ULK2 HUMAN (Q8IYT8) ULK2 MOUSE (Q9QY01) ULK3 ULK3 HUMAN (Q6PHR2) ULK3 MOUSE (Q3U3Q1) ULK4 ULK4 HUMAN (Q96C45) ULK4 MOUSE (Q3V129) WEE1 WEE 1 HUMAN (P30291) WEE1 MOUSE (P47810) WEE2 WEE2 HUMAN (P0C1S8) WEE2 MOUSE (Q66JT0) WNK1 WNK1 HUMAN (Q9H4A3) WNK1 MOUSE (P83741) WNK2 WNK2 HUMAN (Q9Y3S1) WNK2 MOUSE (Q3UH66)
- ADCK protein kinase family ADCK1 ADCK1 HUMAN (Q86TW2) ADCK1 MOUSE (Q9D0L4) ADCK2 ADCK2 HUMAN (Q7Z695) ADCK2 MOUSE (Q6NSR3) ADCK5 ADCK5 HUMAN (Q3MIX3) ADCK5 MOUSE (Q80V03) COQ8A COQ8A HUMAN (Q8NI60) COQ8A MOUSE (Q60936) COQ8B COQ8B HUMAN (Q96D53) COQ8B MOUSE (Q566J8)
- BCKDK BCKD HUMAN (014874) BCKD MOUSE (055028) PDK1 PDK1 HUMAN (Q15118) PDK1 MOUSE (Q8BFP9) PDK2 PDK2 HUMAN (Q15119) PDK2 MOUSE (Q9JK42) PDK3 PDK3 HUMAN (Q15120) PDK3 MOUSE (Q922H2) PDK4 PDK4 HUMAN (Q16654) PDK4 MOUSE (070571)
- ATM ATM HUMAN (Q13315) ATM MOUSE (Q62388) ATR ATR HUMAN (Q13535) ATR MOUSE (Q9JKK8) MTOR MT OR HUMAN (P42345) MTOR MOUSE (Q9JLN9) PIK3CA PK3 C A HUM AN (P42336) PK3CA MOUSE (P42337) PIK3CG PK3 CG HUMAN (P48736) PK3CG MOUSE (Q9JHG7) PRKDC PRKDC HUMAN (P78527) PRKDC MOUSE (P97313) SMG1 SMG1 HUMAN (Q96Q15) SMG1 MOUSE (Q8BKX6)
- kinase target with the kinase binding moiety of a functional kinase binding agent using an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- engagement of the kinase by the kinase binding moiety of a functional kinase binding agent allows for detection, isolation, analyzing, quantification, characterization, etc. of kinases within a sample (e.g., a cell, a cell lysate, a sample, a biochemical solution or mixture, a tissue, an organism, etc.).
- an active variant of KRAS e.g., KRAS4A variant, KRAS4B variant, etc.
- an active variant of KRAS e.g., KRAS4A variant, KRAS4B variant, etc.
- KRAS4A variant, KRAS4B variant, etc. is expressed within the sample or system.
- provided herein are methods of detecting one or more kinases in a sample, the method comprising contacting the sample with a functional kinase binding agent in the presence of an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- a functional kinase binding agent in the presence of an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- methods to isolate one or more kinases from a sample comprising contacting the sample with a functional kinase binding agent in the presence of an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- methods are provided for characterizing a sample by analyzing the presence, quantity, and or population of kinases in the sample (e.g., what kinases are present and/or at what quantities) in the presence of an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.) by contacting the sample with a functional kinase binding agent.
- an active variant of KRAS e.g., KRAS4A variant, KRAS4B variant, etc.
- kinases bound by functional kinase binding agents are detected, quantified, and/or isolated by taking advantage of unique properties of the functional element by any means including electrophoresis, gel filtration, high-pressure or fast-pressure liquid chromatography, mass spectroscopy, affinity chromatography, ion exchange chromatography, chemical extraction, magnetic bead separation, precipitation, hydrophobic interaction chromatography (HIC), or any combination thereof.
- the isolated kinase(s) may be employed for structural and functional studies, for diagnostic applications, for the preparation biological or pharmaceutical reagents, as a tool for the development of drugs, and for studying protein interactions, for the isolation and characterization of protein complexes, etc.
- methods are provided for detecting and/or quantifying a functional kinase binding agent and/or a kinase or protein complex (e.g., comprising a kinase) bound thereto in a sample comprising an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- a functional kinase binding agent and/or a kinase or protein complex e.g., comprising a kinase bound thereto in a sample comprising an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.).
- techniques for detection and/or quantification of the functional kinase binding agents and/or analytes (e.g., kinases) bound thereto depend upon the identity of the detectable element of the functional kinase binding agent (e.g., fluorophore, luciferase, chelated radionuclide, chelated contrast agent, etc.) and/or specific modifications to the functional kinase binding agent (e.g., mass tags (e.g., heavy isotopes (e.g., 13 C, 15 N, 2 H, etc.).
- detectable element of the functional kinase binding agent e.g., fluorophore, luciferase, chelated radionuclide, chelated contrast agent, etc.
- specific modifications to the functional kinase binding agent e.g., mass tags (e.g., heavy isotopes (e.g., 13 C, 15 N, 2 H, etc.).
- a functional kinase binding agent herein comprises a fluorophore or other light emitting detectable element
- the compound and/or analyte (e.g., kinases) bound thereto may be detected/quantified in a sample using systems, devices, and/or apparatuses that are provided to detect, quantitate, or monitor, the amount of light (e.g., fluorescence) emitted, or changes thereto.
- detection, quantification, and/or monitoring are provided by a device, system or apparatus comprising one or more of a spectrophotometer, fluorometer, luminometer, photomultiplier tube, photodiode, nephlometer, photon counter, electrodes, ammeter, voltmeter, capacitative sensors, flow cytometer, CCD, etc.
- a spectrophotometer fluorometer, luminometer, photomultiplier tube, photodiode, nephlometer, photon counter, electrodes, ammeter, voltmeter, capacitative sensors, flow cytometer, CCD, etc.
- functional kinase binding agents may comprise a variety of detectable elements with physical properties based on the interaction and response of the detectable elements to electromagnetic fields and radiation, which can be used to detect the tracers and/or a bound kinase. These properties include absorption in the UV, visible, and infrared regions of the electromagnetic spectrum, presence of chromophores that are Raman active and can be further enhanced by resonance Raman spectroscopy, electron spin resonance activity and nuclear magnetic resonances and molecular mass, e.g., via a mass spectrometer.
- systems comprising: (a) a fusion of a protein kinase (e.g., of Table lA-0 or a variant thereof) and a bioluminescent protein; (b) an active variant of KRAS (e.g., KRAS4A variant, KRAS4B variant, etc.); and (c) a functional kinase binding agent comprising a kinase binding moiety and an energy acceptor (e.g., fluorophore); wherein the emission spectrum of the bioluminescent protein overlaps the excitation spectrum of the energy acceptor (e.g., fluorophore), such that BRET is detectable between the bioluminescent protein and the energy acceptor (e.g., fluorophore) when the kinase binding moiety binds to the protein kinase.
- a protein kinase e.g., of Table lA-0 or a variant thereof
- KRAS e.g., KRAS
- KRAS and related cell signaling pathways
- MAPK pathway the cell signaling events modulated by mutant KRAS activity are not completely elucidated. Therefore, methods to determine the cellular processes and novel oncogenic pathways influenced KRAS activity are critical for ongoing drug discovery efforts.
- an active KRAS variant may result in activation of a signal transduction pathway or other cellular process.
- Activation of signal transduction pathways generally increases kinase post-translational modifications events (e.g., phosphorylation).
- kinase post-translational modifications events e.g., phosphorylation
- altered kinase phosphorylation is commensurate with enhanced target engagement potency. Therefore, activation of KRAS signaling pathways may cause a change in kinase post-translational modifications commensurate with enhanced kinase target engagement. Increases in kinase target engagement could therefore serve as a detectable signal to elucidate novel KRAS-related cellular processes. It is contemplated that a method relying on changes in such signals is capable of uncovering novel targets for therapeutic intervention and drug development.
- YGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM SEQ ID NO: 17 - NanoLuc (nucleotide sequence) atgaaacatcaccatcaccatcatgcgatcgccatggtcttcacactcgaagatttcgttggggactg gcgacagacagccggctacaacctggaccaagtccttgaacagggaggtgtgtgtccagtttgttcaga atctcggggtgtccgtaactccgatccaaaggattgtcctgagcggtgaaaatgggctgaagatcgac atccatgtcatcatcccgtatgaaggtctgagcggcgaccaaatgggccagatcgaaaaatttttaa ggtggtgtaccc
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063028729P | 2020-05-22 | 2020-05-22 | |
US202063109103P | 2020-11-03 | 2020-11-03 | |
PCT/US2021/033703 WO2021237118A2 (en) | 2020-05-22 | 2021-05-21 | Enhancement of kinase target engagement |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4153770A2 true EP4153770A2 (en) | 2023-03-29 |
Family
ID=76959042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21742931.5A Pending EP4153770A2 (en) | 2020-05-22 | 2021-05-21 | Enhancement of kinase target engagement |
Country Status (4)
Country | Link |
---|---|
US (1) | US20210363565A1 (en) |
EP (1) | EP4153770A2 (en) |
JP (1) | JP2023526677A (en) |
WO (1) | WO2021237118A2 (en) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US103A (en) | 1836-12-10 | Process | ||
US8669A (en) | 1852-01-20 | John waters | ||
US4812409A (en) | 1986-01-31 | 1989-03-14 | Eastman Kodak Company | Hydrolyzable fluorescent substrates and analytical determinations using same |
US4810636A (en) | 1986-12-09 | 1989-03-07 | Miles Inc. | Chromogenic acridinone enzyme substrates |
US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
US6162931A (en) | 1996-04-12 | 2000-12-19 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
US7393656B2 (en) | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
JP4748685B2 (en) | 2003-01-31 | 2011-08-17 | プロメガ コーポレイション | Covalent tethering of functional groups to proteins |
US7429472B2 (en) | 2003-01-31 | 2008-09-30 | Promega Corporation | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
US7425436B2 (en) | 2004-07-30 | 2008-09-16 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
PE20081636A1 (en) * | 2007-01-26 | 2009-01-10 | Smithkline Beecham Corp | ANTHRANILAMIDE INHIBITORS FOR AURORA KINASE |
PT2990478T (en) | 2009-05-01 | 2017-05-08 | Promega Corp | Synthetic oplophorus luciferases with enhanced light output |
EP2635595B1 (en) | 2010-11-02 | 2019-01-09 | Promega Corporation | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
WO2014052653A1 (en) | 2012-09-26 | 2014-04-03 | Promega Corporation | Real-time monitoring |
CN117024548A (en) | 2013-03-15 | 2023-11-10 | 普洛麦格公司 | Activation of bioluminescence by structural complementation |
WO2014176700A1 (en) * | 2013-05-01 | 2014-11-06 | Université de Montréal | Biosensors for ras-dependent signaling pathways and use thereof |
US9924073B2 (en) | 2016-02-15 | 2018-03-20 | Promega Corporation | Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof |
JP7212612B2 (en) | 2016-07-28 | 2023-01-25 | プロメガ コーポレイション | coelenterazine analog |
US9943505B2 (en) | 2016-09-09 | 2018-04-17 | Corcept Therapeutics, Inc. | Glucocorticoid receptor modulators to treat pancreatic cancer |
JP7432529B2 (en) * | 2018-05-30 | 2024-02-16 | プロメガ コーポレイション | Broad Spectrum Kinase Binders |
-
2021
- 2021-05-21 WO PCT/US2021/033703 patent/WO2021237118A2/en unknown
- 2021-05-21 JP JP2022571786A patent/JP2023526677A/en active Pending
- 2021-05-21 US US17/327,319 patent/US20210363565A1/en active Pending
- 2021-05-21 EP EP21742931.5A patent/EP4153770A2/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021237118A2 (en) | 2021-11-25 |
US20210363565A1 (en) | 2021-11-25 |
JP2023526677A (en) | 2023-06-22 |
WO2021237118A3 (en) | 2022-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230194515A1 (en) | Broad spectrum kinase binding agents | |
Tian et al. | Fluorescent probes for the visualization of cell viability | |
Titeca et al. | Discovering cellular protein‐protein interactions: Technological strategies and opportunities | |
Alamudi et al. | Advances in the design of cell-permeable fluorescent probes for applications in live cell imaging | |
Ahn et al. | Label-free, single protein detection on a near-infrared fluorescent single-walled carbon nanotube/protein microarray fabricated by cell-free synthesis | |
US9810690B2 (en) | Method for screening inhibitors of Ras | |
Morris | Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes | |
Gonçalves | Fluorescent labeling of biomolecules with organic probes | |
Krueger et al. | Fluorescent amino acids: modular building blocks for the assembly of new tools for chemical biology | |
Liu et al. | A rapid SNAP-tag fluorogenic probe based on an environment-sensitive fluorophore for no-wash live cell imaging | |
US20060211075A1 (en) | Enzyme sensors including environmentally sensitive or fluorescent labels and uses thereof | |
Guo et al. | Phosphate ion targeted colorimetric and fluorescent probe and its use to monitor endogeneous phosphate ion in a hemichannel-closed cell | |
MacNevin et al. | Membrane-permeant, environment-sensitive dyes generate biosensors within living cells | |
JP2009513681A (en) | Kinase and ubiquitination assays | |
Huber et al. | Spectroscopic characterization of coumarin-stained beads: quantification of the number of fluorophores per particle with solid-state 19F-NMR and measurement of absolute fluorescence quantum yields | |
JPWO2006126570A1 (en) | Multiple simultaneous analysis methods for biological reactions or in vivo state changes | |
Wu et al. | Tunning intermolecular interaction of peptide-conjugated AIEgen in nano-confined space for quantitative detection of tumor marker secreted from cells | |
Wang et al. | Live cell visualization of multiple protein–protein interactions with BiFC rainbow | |
Robers et al. | Single tracer-based protocol for broad-spectrum kinase profiling in live cells with NanoBRET | |
Yang et al. | Colorimetric and fluorescent dual-signal chemosensor for lysine and arginine and its application to detect amines in solid-phase peptide synthesis | |
US20090099029A1 (en) | Methods and substrates for conducting assays | |
Chen et al. | Fluorogenic reactions in chemical biology: seeing chemistry in cells | |
Zhang et al. | Accurate identification of exosomes based on proximity-induced autonomous assembly of DNAzyme wires | |
WO2008071937A1 (en) | Novel fluorescent kinase ligands and assays employing the same | |
US20210363565A1 (en) | Enhancement of kinase target engagement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20221117 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
PUAG | Search results despatched under rule 164(2) epc together with communication from examining division |
Free format text: ORIGINAL CODE: 0009017 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240513 |
|
B565 | Issuance of search results under rule 164(2) epc |
Effective date: 20240513 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 403/12 20060101ALI20240507BHEP Ipc: C07D 241/20 20060101ALI20240507BHEP Ipc: C12Q 1/48 20060101AFI20240507BHEP |